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1. Summary 
 
Renal reabsorption of inorganic phosphate (Pi) is mainly mediated by the 
Na-dependent Pi-cotransporter NaPi-IIa that is expressed in the brush border 
membrane (BBM) of renal proximal tubules. Regulation and apical expression 
of NaPi-IIa are known to depend on a network of interacting proteins. Most of 
the interacting partners identified so far associate with the C-terminal PDZ-
binding motif (TRL) of NaPi-IIa. In a novel membrane yeast-two-hybrid     
(MYTH 2.0) screen of a mouse kidney library using the TRL-truncated 
cotransporter as bait, GABARAP was identified as a new interacting partner of 
NaPi-IIa. 
GABARAP mRNA and protein are present in renal tubules and the 
interaction of NaPi-IIa and GABARAP was confirmed using GST-pull downs 
from BBM and co-immunoprecipitations from transfected HEK293 cells. Amino 
acids 36-68 of GABARAP were identified as a molecular determinant for the 
described interaction.  
The in vivo effects of this interaction were studied in a murine model. 
GABARAP-/- mice have a reduced urinary excretion of Pi, a higher Na-
dependent 32Pi-uptake into renal BBMV, and an increased expression of    
NaPi-IIa in BBM as compared to GABARAP+/+ mice. The expression of 
NHERF1, an important scaffold for the apical expression of NaPi-IIa, is also 
increased in GABARAP-/- mice.  
Although baseline expression of NaPi-IIa is elevated, the absence of 
GABARAP does not interfere with the parathyroid hormone (PTH)-induced 
endocytosis of NaPi-IIa. Similarly, downregulation of NaPi-IIa induced by high 
content of Pi in the diet proceeds unaffected in GABARAP-/- mice. However, 
upregulation of the cotransporter in response to a chronic low Pi diet is greater 
in GABARAP-/- than in GABARAP+/+ mice. Acute dietary regulation of NaPi-IIa is 
similar in GABARAP-/- and in GABARAP+/+ mice.  
In summary, GABARAP interacts with NaPi-IIa and controls the 
abundance of the cotransporter. Phosphaturic factors (PTH, high Pi diet) reduce 
the expression of NaPi-IIa to similar levels in GABARAP-/- and in GABARAP+/+ 
mice, whereas NaPi-IIa expression is elevated in GABARAP-/- mice in the 
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absence of phosphaturic stimulus (normal diet) and under Pi conserving 
settings (low Pi diet). Therefore, we suggest that GABARAP exerts its effect on 
NaPi-IIa neither in the biosynthetic nor in the degradative pathway, but instead 
negatively influences NaPi-IIa basal turnover and/or half-life time in vivo.  
6 
 
2. Zusammenfassung 
 
Die Reabsorption von anorganischem Phosphat (Pi) in der Niere wird 
hauptsächlich durch den Na-abhängigen Pi-Kotransporter NaPi-IIa vermittelt. 
Dieser ist in der Bürstensaummembran von proximalen Tubuluszellen 
exprimiert. Sowohl die Regulation als auch die Expression von NaPi-IIa in der 
apikalen Membran ist von einem Netzwerk von interagierenden Proteinen 
abhängig. Die meisten der bisher identifizierten Proteine dieses Netzwerks 
interagieren mit einer C-terminalen PDZ-bindenden Domäne (TRL) von      
NaPi-IIa. In einer neuen Hefe-zwei-Hybrid Durchsuchung mit einer C-terminalen 
Deletionsmutante (ΔTRL) von NaPi-IIa als Köderprotein wurde GABARAP als 
neuer interagierender Partner von NaPi-IIa identifiziert. 
GABARAP mRNA sowie Protein sind in proximalen Tubuli exprimiert. Die 
Interaktion zwischen NaPi-IIa und GABARAP wurde sowohl durch „GST-pull 
down“-Experimente als auch mittels Ko-Immunpräzipitation verifiziert. Die 
Aminosäuren 36-64 von GABARAP stellen eine molekulare Determinante für 
die Interaktion dar. 
Die Effekte dieser Interaktion konnten mittels eines GABARAP-
defizienten Mausmodells in vivo untersucht werden. Im Vergleich zu 
GABARAP+/+ Mäusen weisen GABARAP-/- Mäuse eine erniedrigte Pi-Exkretion 
im Urin, eine erhöhte Aufnahme von Pi in Bürstensaummembranvesikel sowie 
eine vermehrte Expression von NaPi-IIa in der renalen Bürstensaummembran 
auf. Zusätzlich wurde in GABARAP-/- Mäusen eine vermehrte Expression von 
NHERF1, eines wichtigen Ankerproteins für die apikale Lokalisation von     
NaPi-IIa, nachgewiesen. 
Trotz der vermehrten Expression von NaPi-IIa unter normalen 
Bedingungen  ist die durch das Parathormon induzierte Endozytose von      
NaPi-IIa in GABARAP-defizienten Mäusen nicht beeinträchtigt. Ebenso hat das 
Fehlen von GABARAP keinen Einfluss auf die Herunterregulation von NaPi-IIa 
durch eine chronisch verabreichte Pi-reiche Diät. Hingegen ist die 
Heraufregulation von NaPi-IIa als Antwort auf eine chronisch verabreichte      
Pi-arme Diät in GABARAP-/- Mäusen im Vergleich zu GABARAP+/+ Mäusen 
verstärkt. Die akute Regulation von NaPi-IIa durch Pi-arme/Pi-reiche Diät 
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innerhalb weniger Stunden ist durch das Fehlen von GABARAP nicht 
beeinträchtigt.  
Zusammenfassend lässt sich sagen, dass GABARAP mit NaPi-IIa 
interagiert und die apikale Expression des Kotransporters kontrolliert. 
Phosphaturische Faktoren (Pi-reiche Diät, Parathormon) erniedrigen die 
Expression von NaPi-IIa auf ein vergleichbares Niveau in GABARAP-/- und 
GABARAP+/+ Mäusen. Im Gegensatz hierzu ist die Expression von NaPi-IIa in 
GABARAP-/- Mäusen in Abwesenheit phosphaturischer Faktoren (normale Diät) 
sowie unter phosphat-konservierenden Bedingungen (Pi-arme Diät) verstärkt. 
Diese Daten weisen darauf hin, dass GABARAP weder für den 
biosynthetischen noch für den degradierenden Pfad eine Rolle spielt. 
Stattdessen scheint GABARAP die stationäre Expression und/oder die 
Lebensdauer von NaPi-IIa in der Bürstensaummembran in vivo zu beeinflussen.  
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3. Introduction 
 
3.1 The kidneys 
The kidneys are bean-shaped organs that lie behind the peritoneum on 
each side of the vertebral column. Their main function is to regulate the 
electrolyte composition, acid-base balance and the volume of extracellular 
fluids. Furthermore, metabolic waste products and toxins are eliminated from 
the body by excretion in the urine. Although both kidneys together comprise to 
only ~0.5% of the body weight, they receive ~20% of the cardiac output. The 
blood enters the kidney via the renal artery and leaves the kidney through the 
renal vein after filtration. The urine exits the kidney through the ureters. The 
ureters from both kidneys empty into the bladder. 
A cut section through the kidney reveals two basic layers: the granular 
cortex and an inner region called medulla (Fig.1). The granular appearance of 
the cortex is due to the presence of microscopic clusters of capillaries and 
convoluted epithelial tubules. In contrast to the cortex, tubules and blood 
vessels in the medulla are arranged in a parallel manner, resulting in a striated 
appearance. 
 Each human kidney consists of ~1 million nephrons, the functional 
subunits of the kidney. The blood is filtered through the endothelial wall of a tuft 
of capillaries that is called glomerulus. These capillaries are surrounded by 
podocytes which form a filtration barrier that allows filtration of water and small 
solutes but not of large molecules like proteins or even blood cells. The blood 
filtrate enters the nephron at the Bowman`s capsule which covers the 
glomerulus. From there, it passes through different subdivisions of the nephron 
and is converted into concentrated urine during its passage. From the 
Bowman`s space, the ultrafiltrate enters the proximal tubule. Based on its 
appearance, this division can be subdivided into the proximal convoluted tubule 
and the proximal straight tubule. The cells of the proximal tubule are 
characterized by an extensive amplification of both, the apical (luminal) and the 
basolateral (peritubular) membrane. Due to its infoldings, the apical membrane 
is also termed brush border membrane (BBM). The enlargement of the apical 
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surface area correlates with the main function of this nephron segment which is 
the reabsorption of the bulk of filtered fluid and solutes. The next subdivision of 
the nephron is the loop of Henle that is formed by the descending and 
ascending thin limbs and the thick ascending limb. The loop of Henle facilitates 
concentration of the urine due to a counterflow mechanism. The loop of Henle is 
followed by the distal convoluted tubule which terminates in the connecting 
tubule and finally in the collecting duct. These are the sites of fine control of salt 
and water excretion.  
 Two populations of nephrons can be distinguished. Superficial or cortical 
nephrons have only short loops of Henle. They account for the majority of 
nephrons and have mainly excretory and regulatory functions, whereas 
juxtamedullary nephrons with their long loops of Henle play a major role in 
concentration and dilution of the urine (Boron and Boulpaep 2005). 
 
Figure 1: Anatomy of the kidney and the nephron.  
(modified from www.uptodate.com) 
10 
 
3.2 Inorganic phosphate homeostasis 
Inorganic phosphate plays an important role in a variety of cellular processes 
such as energy metabolism, nucleic acid synthesis, membrane function and 
bone mineralization. In addition, phosphorylation of proteins is a major 
regulatory mechanism involved in many cellular processes such as cell 
signaling and control of protein activity.  
In the body, approximately 85% of the total phosphate is stored in the 
skeleton and teeth, whereas the remaining phosphate is distributed in soft 
tissues (14%) and in extracellular fluids (1%). Phosphate exists in two forms in 
the blood: in an organic form as phospholipids or phosphate esters and in the 
inorganic form - at the physiological blood pH 7.4 - mainly as divalent 
phosphate anion HPO42-. The inorganic phosphate (Pi) accounts for ~30% of 
the total plasma phosphate. Of this Pi, only 85-90% can be freely filtered in the 
kidney whereas the remaining 10-15% is bound to proteins.  
Because of its involvement in diverse biological processes and its limited 
solubility in the presence of divalent cations, the concentration of free Pi in 
extracellular as well as in intracellular compartments needs to be balanced in a 
millimolar range. Several organs are involved in Pi homeostasis. The daily need 
for Pi is covered by absorption of ~70% of the ingested Pi from the diet in the 
small intestine. The absorbed Pi is released into the blood and either deposited 
in the compartments described before or filtered in the kidney. Renal Pi 
excretion can be adjusted in a tight and rapid manner to hormones and 
metabolic factors that influence Pi homeostasis. In contrast, intestinal 
absorption is adjusted rather slowly and is believed to play only a minor role in 
the control of Pi homeostasis. In a situation of neutral Pi balance, the amount of 
Pi that is absorbed in the small intestine equals the amount of Pi that is 
excreted in the urine. Under physiological conditions, 80-90% of the Pi that is 
filtered in the glomeruli is reabsorbed in the renal proximal tubules. 
The proximal tubule reabsorbs Pi by the transcellular route. The rate-
limiting step occurs at the apical membrane of the proximal tubular cells, which 
is the site for a secondary active transport process. In this transport process the 
electrochemical sodium gradient is utilized to mediate uphill transport of Pi into 
proximal tubular cells. In contrast to the apical entry of Pi into the cells, the 
basolateral exit of Pi remains poorly understood. 
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3.3 Phosphate transporters 
Several mammalian phosphate transporters have been identified and 
characterized at the molecular level. These phosphate transporters have been 
grouped into three different protein families: type I, type II                               
and type III. According to the human genome database 
(http://www.gene.ucl.ac.uk/nomenclature) the transporters are assigned to the 
solute carrier series SCL17, SLC34 and SLC20.  
 
3.3.1 Type I NaPi cotransporters (SLC17) 
Type I NaPi cotransporters are expressed in the kidney, liver and brain. 
Within the kidney, the type I NaPi cotransporter is localized in the brush-border 
membrane of proximal tubules (Biber, Custer et al. 1993). Expression in 
Xenopus laevis oocytes revealed that the type I NaPi cotransporter mediates 
sodium-dependent transport of Pi at high extracellular Pi concentrations. 
However, in addition to Pi, the type I NaPi-cotransporter transports a variety of 
other anions and might also possess chloride channel activity (Busch, Schuster 
et al. 1996). The type I NaPi cotransporter is not regulated by factors that are 
known to influence renal Pi reabsorption (Werner, Dehmelt et al. 1998). 
Interestingly, a type I related NaPi cotransporter is likely to be involved in 
vesicular glutamate uptake in the brain (Bellocchio, Reimer et al. 2000).   
 
3.3.2 Type II NaPi cotransporters (SLC34) 
The SLC34 family comprises three members: NaPi-IIa, NaPi-IIb and 
NaPi-IIc. Type II NaPi cotransporters are expressed in several epithelial tissues. 
In the kidney (NaPi-IIa and NaPi-IIc) and in the small intestine (NaPi-IIb), these 
transporters are located in apical membranes and represent the rate-limiting 
step of transepithelial Pi transport (Murer, Forster et al. 2004) (Fig. 2). Unlike 
type I NaPi cotransporters, members of the type II NaPi family mediate 
exclusively Pi transport and this transport is strictly sodium-dependent. Due to 
their different Na+:Pi stoichiometry, the Pi transport by NaPi-IIa and NaPi-IIb is 
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electrogenic whereas NaPi-IIc is electroneutral. The abundance of type II NaPi 
cotransporters is controlled by factors that influence Pi homeostasis. 
NaPi-IIa is expressed primarily in renal proximal tubules, where it is 
localized in microvilli that form the brush border membrane. In addition, 
expression of NaPi-IIa is also found in bone cells and neurons (Gupta, Guo et 
al. 1997; Hisano, Haga et al. 1997). Within the kidney, NaPi-IIa expression is 
restricted to the brush border membrane of proximal tubules. Under standard 
dietary conditions, NaPi-IIa expression is highest in proximal convoluted tubules 
(S1, S2) and gradually decreased towards the end of the proximal straight 
tubule (S3). Expression of NaPi-IIa is more pronounced in juxtamedullary than 
in superficial nephrons (Custer, Lotscher et al. 1994). Thus, NaPi-IIa expression 
in the kidney matches with the main sites of renal Pi reabsorption. 
 NaPi-IIb expression has been described in the small intestine and other 
organs such as lung, liver and mammary glands. In the small intestine, NaPi-IIb 
is localized in the brush border membrane of enterocytes and mediates Pi 
absorption from the diet (Hilfiker, Hattenhauer et al. 1998). 
 NaPi-IIc expression is found exclusively in renal proximal tubules. It has 
been described to be a growth-related transporter with a higher expression in 
weaning mice and a progressive decrease with age (Segawa, Kaneko et al. 
2002). However, young NaPi-IIc-/- mice show hypercalciuira and hypercalcemia 
but not hypophosphatemia. Furthermore, renal NaPi cotransport activity and 
urinary Pi excretion is not affected by the loss of NaPi-IIc (Segawa, Onitsuka et 
al. 2009). 
Based on the severe renal Pi wasting phenotype of NaPi-IIa-/- mice 
(Beck, Karaplis et al. 1998), it has been proposed that NaPi-IIa is the major Pi 
transporter in the adult murine kidney, whereas NaPi-IIc was considered to 
playing only a minor role. However, mutations of NaPi-IIc identified in families 
with several hypophosphatemic syndromes and in particular the detectable 
phenotype in the heterozygotes (Bergwitz, Roslin et al. 2006; Ichikawa, 
Sorenson et al. 2006; Lorenz-Depiereux, Benet-Pages et al. 2006) points to 
either dramatic differences between humans and mice or an incomplete 
understanding of renal handling of Pi. 
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Figure 2: SLC34 transporters and Pi homeostasis. 
 
 
3.3.3 Type III NaPi cotransporters (SLC20) 
The most recent family of NaPi cotransporters that has been described is 
the SLC20 family (Collins, Bai et al. 2004). Their members were originally 
identified as retroviral receptors. Later it has been shown that both receptors of 
this family (now renamed into PiT-1 and PiT-2) induce Pi transport in a sodium-
dependent manner after expression in Xenopus laevis oocytes (Kavanaugh, 
Miller et al. 1994). Both proteins are almost ubiquitously expressed in rat 
tissues. Interestingly, PiT-2 related mRNA expression increases in response to 
incubation of cells in Pi-free medium (Chien, O'Neill et al. 1998). Recent 
findings suggest that PiT-2 might contribute to renal Pi reabsorption based on 
its localization in the brush border membrane in proximal tubules (Villa-Bellosta 
R., Ravera S., in press). Its precise physiological role for Pi homeostasis 
remains to be established. 
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3.4 NaPi-IIa 
Knock-out of the gene encoding for NaPi-IIa (Npt2) led to the conclusion 
that the bulk of Pi is reabsorbed by this cotransporter. Pi transport into brush 
border membrane vesicles isolated from NaPi-IIa-/- mice was reduced by 70%, 
consistent with the hypophosphatemic state of these animals (Beck, Karaplis et 
al. 1998). The remaining 30% of NaPi-transport activity was attributed to the 
maximally increased expression of NaPi-IIc (Tenenhouse, Martel et al. 2003). 
As described in the above section, also other Pi-transporters, such as PiT-2, 
might contribute to the remaining transport activity in NaPi-IIa-/- mice. However, 
these findings suggest that in adult wild-type mice, renal Pi reabsorption is 
largely determined by the transport activity of NaPi-IIa. 
 
3.4.1 General characteristics 
NaPi-IIa consists of 635 amino acids (Magagnin, Werner et al. 1993) and 
migrates with an apparent molecular weight of 80-90 kDa in SDS-gels under 
non-reducing conditions. Based on data obtained from cysteine scanning, 
hydropathy analysis and epitope tagging studies a structural model of NaPi-IIa 
has been proposed (Fig. 3). According to this model, NaPi-IIa has eight 
transmembrane domains with both, the N- and the C-terminus facing the 
intracellular compartment. A large extracellular domain (ECL2) contains two N-
glycosylation sites. Furthermore, this domain links two halves of the protein that 
contain conserved repeated sequences. These repeated motifs may form two 
opposed reentrant loops which then constitute the Pi transport pathway (Biber, 
Hernando et al. 2008).  
The preferred substrate of NaPi-IIa is divalent Pi. Due to the transport 
stoichiometry of three Na+ and one HPO42- ions, NaPi-IIa is an electrogenic 
cotransporter that transports one net positive charge per cycle into the cell. The 
binding order of Na+ and HPO42- ions has been revealed. The transport cycle is 
initiated by the binding of one Na+, followed by binding of the HPO42- and 
subsequent binding of two Na+ ions (Forster, Loo et al. 1999). Protons can 
interact with the empty transporter and also with the final Na+ binding steps. 
Therefore, NaPi-IIa cotransport is pH-dependent with higher transport rates at 
more basic external pH values (Forster, Kohler et al. 2002).  
15 
 
 
 
Figure 3: Proposed structural model of NaPi-IIa. 
 
3.4.2 Regulation of NaPi-IIa 
Pi homeostasis is mainly controlled by adjustments of Pi reabsorption in 
the kidney. Many hormones and metabolic factors operate primarily on this 
step. Theoretically, Pi reabsorption in renal proximal tubules could be adjusted 
by three different mechanisms: changing the abundance of the transporter, 
alterations of the apparent affinities for the substrates or changes of the lipid 
composition which may influence the preferred protein conformation and thus 
influence transport activity. Pi reabsorption via NaPi-IIa is controlled by 
adjusting the amount of transporters that reside in the brush border membrane 
rather than changing their intrinsic transport activity. On the one hand, 
membrane abundance of NaPi-IIa depends on the biosynthetic pathway and 
membrane insertion. On the other hand, NaPi-IIa downregulation occurs by 
endocytotic membrane retrieval. Endocytosed NaPi-IIa proteins are degraded in 
lysosomes with no or little recycling back to the membrane (Keusch, Traebert et 
al. 1998). 
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Several Pi wasting disorders have been described that involve changes 
of the expression of NaPi-IIa. These are the inherited disorders X-linked 
hypophosphatemia (XLX), autosomal dominant hypophosphatemic rickets 
(ADHR) and the acquired disorder oncogenic hypophosphatemic osteomalacia 
(OHO). Studies related to these disorders revealed the importance of two 
genes, PHEX and FGF23, for NaPi-IIa expression (Fukumoto and Yamashita 
2002; Tenenhouse and Sabbagh 2002) (Fig. 4). The PHEX gene encodes a 
protein that is a member of a family of membrane-bound metalloproteases. It 
has been postulated that PHEX plays a role in the activation or inactivation of 
peptide factors involved in the regulation of renal Pi reabsorption (Takeda, 
Yamamoto et al. 2004). FGF23 might be a substrate of this metalloprotease and 
thus accumulates when the PHEX gene harbors inactivating mutations. 
Elevated serum levels of FGF23 lead to a decreased NaPi-IIa abundance and 
Pi wasting. As expected, the opposite effect (increased Pi reabsorption) was 
found in FGF23-/- mice (Shimada, Kakitani et al. 2004). It has been shown that 
FGF23 might be involved in dietary regulation of Pi reabsorption. FGF23 
controls the effect of the diet on NaPi-IIa independently on changes of other 
phosphaturic hormones, such as PTH, in the blood plasma (Segawa, Kawakami 
et al. 2003).  
Interestingly, knock-out of a gene encoding for a type I membrane protein 
named Klotho results in a phenotype that has striking similarities to the one 
observed in FGF23-/- mice (Razzaque 2008). Hyperphosphatemia in klotho-/- 
mice correlates with increased levels of NaPi-IIa and NaPi-IIc (Segawa, 
Yamanaka et al. 2007). In addition, klotho-/- mice have highly elevated serum 
FGF23 levels, possibly due to an end-organ resistance to FGF23 and a positive 
feedback-loop (Stubbs, Liu et al. 2007). Studies have shown that Klotho acts as 
a cofactor which allows FGF23 to bind to its receptor complex with much higher 
affinity than to FGFR alone and therefore facilitates subsequent signaling 
activities of the receptor (Kurosu, Ogawa et al. 2006; Goetz, Beenken et al. 
2007; Medici, Razzaque et al. 2008).  
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Figure 4: The phosphaturic hormone FGF23.  
(modified from Stubbs et al., Seminars in Dialysis-Vol. 20, 2007) 
 
 
3.4.2.1 Dietary Phosphate 
One factor that controls NaPi-IIa membrane expression and thus renal 
tubular reabsorption of Pi is the dietary Pi intake, with high Pi diet decreasing 
and low Pi diet increasing the expression of NaPi-IIa in the proximal microvilli 
(Fig. 5). Upregulation of NaP-IIa upon intake of a low Pi diet results in the 
presence of NaPi-IIa in superficial nephrons which, as mentioned before, 
express very little amounts of the cotransporter in normal dietary conditions. 
Adaptation in response to dietary Pi content can be observed within less than 
one hour (acute adaptation) and remains stable even during prolonged dietary 
administration (chronic adaptation).  
Acute changes are independent on transcriptional regulation of NaPi-IIa, 
whereas the situation for the chronic adaptation is not that clear. In weaning 
mice chronically fed with a low Pi diet NaPi-IIa protein increase is paralleled by 
an increase of its mRNA (Kido, Miyamoto et al. 1999), whereas in adult mice no 
such transcriptional regulation could be observed after chronic feeding with a 
low Pi diet (Madjdpour, Bacic et al. 2004).  
Acute increase of NaPi-IIa protein in the apical membrane in response to 
a low dietary Pi content is independent on de novo protein synthesis since it 
could not be blocked by cycloheximide, an inhibitor of translational elongation in 
eukaryotic organisms (Levine, Ho et al. 1986). This observation could be 
explained by the translocation of a subapical pool of NaPi-IIa cotransporters into 
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the apical membrane. However, the existence of such an intracellular pool of 
NaPi-IIa cotransporters is not proven.  
 
                     
Figure 5: Dietary regulation of NaPi-IIa in mice fed with a low or a high Pi diet for five days. 
 
 
Opposed to the effect of a low Pi diet, intake of a high dietary Pi content 
leads to a decrease of NaPi-IIa membrane abundance and an increase of 
urinary Pi excretion. Also this adaptation occurs in a rapid way and is completed 
within four hours after intake of a high Pi diet (Capuano, Bacic et al. 2005). The 
internalized NaPi-IIa undergoes lysosomal degradation.  
 In addition to NaPi-IIa, also NaPi-IIc is regulated by dietary Pi intake. 
However, the mechanisms seem to differ from those involved in NaPi-IIa 
regulation. Acute regulation of NaPi-IIc is not observed (Segawa, Yamanaka et 
al. 2005) and chronic regulation of NaPi-IIc involves transcriptional changes 
(Madjdpour, Bacic et al. 2004). 
 
 
3.4.2.2 PTH 
The parathyroid hormone (PTH) is one of the best understood humoral 
factors which control the apical expression of NaPi-IIa (Fig. 6). PTH is a potent 
phosphaturic hormone that causes rapid internalization of NaPi-IIa via the 
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pathway of receptor-mediated endocytosis. Internalization occurs at the 
microvillar clefts, possibly in clathrin-coated vesicles (Bacic, Lehir et al. 2006). 
As mentioned before, morphological and biochemical data point to a 
subsequent lysosomal degradation of NaPi-IIa (Keusch, Traebert et al. 1998). 
PTH-induced downregulation of NaPi-IIa is independent on transcriptional 
changes.  
 
 
Figure 6: PTH-induced downregulation of NaPi-IIa. 
(modified from Capuano et al., Am J Physiol Cell Physiol. Vol. 292, 2007)  
 
 
The signaling events that lead to membrane retrieval of NaPi-IIa 
cotransporters have been studied in great detail (Fig. 7). PTH-receptors are    
G-protein coupled receptors which are localized on the apical as well as on the 
basolateral membrane of renal proximal tubular cells. However, their 
intracellular signaling pathways are not identical due to their coupling to 
different subfamilies of G-proteins (Traebert, Volkl et al. 2000). The apical PTH-
receptor activates preferentially the phospholipase C (PLC)/ protein kinase C 
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(PKC) pathway. Although this PLC activation has been considered to involve 
Gq-proteins, recent data suggest the implication of the Gi/o subfamily (see 3.5.1). 
In contrast, the basolateral PTH-receptor is linked to the subfamily of              
Gs-proteins. Gs-proteins activate the adenylyl cyclase (AC). Generation of the 
second messenger cAMP leads to activation of the protein kinase A (PKA). 
Despite this difference in the initial PTH-induced signaling, both pathways 
partially converge at the level of the MAP-kinases ERK1/2. Pharmacological 
inhibition of ERK1/2 activation impairs the PTH-induced NaPi-IIa internalization 
in kidney slices (Bacic, Schulz et al. 2003). 
The molecular link between ERK1/2 activation and endocytosis of    
NaPi-IIa is not yet understood. To date, there is no convincing evidence for a 
phosphorylation of NaPi-IIa itself. Instead, phosphorylation is believed to play a 
role on the level of NaPi-IIa interacting proteins which are required for its 
localization and regulation (see 3.5.1). 
 
 
Figure 7: Signaling events leading to the PTH-induced internalization of NaPi-IIa. 
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Interestingly, PTH does not induce internalization of NaPi-IIb. This 
insensitivity of NaPi-IIb enabled the identification of the molecular domains of 
NaPi-IIa that are required for its PTH-induced downregulation. Chimeras of 
NaPi-IIa and NaPi-IIb were tested for their PTH-responsiveness. These studies 
led to the identification of a dibasic KR-motif within the third intracellular loop 
which is strictly required for the PTH-induced endocytosis of NaPi-IIa (Karim-
Jimenez, Hernando et al. 2000).  
 
 
3.5 NaPi-IIa interacting proteins 
The localization of NaPi-IIa in the apical brush border membrane and its 
controlled expression is believed to depend on a network of interacting proteins. 
Theoretically, these interacting proteins could either regulate the trafficking of 
NaPi-IIa to the apical membrane, they could act as scaffolding proteins to 
stabilize NaPi-IIa in the membrane or they could be required for the correct 
organization of the signaling complexes that lead to internalization of the 
cotransporter. The latter mechanism has been described for the PKA-mediated 
regulation and internalization of the sodium-proton exchanger NHE3, a 
transport protein that is also localized in apical brush border membranes of 
renal proximal tubules (Weinman, Steplock et al. 2003). 
Different yeast-two-hybrid screens were performed to identify such 
interacting partners of NaPi-IIa (Fig. 8). In one of them, the PTH-responsive 
third intracellular loop of NaPi-IIa was used as bait. PEX19, a human 
peroxisomal farnesylated protein was identified as a NaPi-IIa interacting protein 
in this screen. The interaction with PEX19 depends on the presence of the KR 
motif of NaPi-IIa. Overexpression of PEX19 has been shown to induce 
internalization of NaPi-IIa in OK cells (Ito, Iidawa et al. 2004), a cell line 
obtained from opossum kidney that retaines properties of proximal epithelia. 
 Another yeast-two-hybrid screen was performed using the N-terminal 
domain of NaPi-IIa as bait. Results obtained from this screen suggested that 
MAP17, a small membrane-associated protein interacts with the N-terminus of 
NaPi-IIa. Interestingly, MAP17 additionally interacts with the PSD-95/Drosophila 
discs large/ZO-1 (PDZ)-domain containing protein PDZK1. PDZK1 interacts 
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also with the C-terminus of NaPi-IIa directly (see later). The physiological role of 
the interaction between NaPi-IIa and MAP17 has been studied with somewhat 
conflicting results. An earlier study reported that MAP17 is required for apical 
positioning of PDZK1 based on co-expression of both interacting proteins in OK 
cells (Pribanic, Gisler et al. 2003). In contrast to this observation, other 
investigators suggest that co-expression of MAP17 and PDZK1 in OK cells 
leads to a translocation of the whole MAP17/PDZK1/NaPi-IIa complex to the 
trans-Golgi network in a PKC-dependent manner (Lanaspa, Giral et al. 2007). 
However, it has been shown that PTH-induced activation of PKC in mice did not 
induce a change in localization of MAP17 or PDZK1 (Pribanic, Gisler et al. 
2003). Thus, the precise role of MAP17 in the regulation of NaPi-IIa is still not 
understood. 
 The last three amino acids at the C-terminus of NaPi-IIa (TRL) constitute 
a PDZ-binding motif. Apical expression of NaPi-IIa depends on the presence of 
this motif as illustrated by the observation that a ΔTRL cotransporter partially 
accumulates intracellularly (Karim-Jimenez, Hernando et al. 2001).            
Yeast-two-hybrid analysis with the C-terminal domain as bait led to the 
identification of numerous PDZ-domain containing proteins as potential NaPi-IIa 
interacting partners (Gisler, Stagljar et al. 2001). Interestingly, all four members 
of the sodium-hydrogen exchanger regulatory factor (NHERF)-family  
(NHERF1-4) were identified as interacting proteins in this screen (Gisler, 
Stagljar et al. 2001). These four PDZ-proteins are expressed in or in close 
proximity to the proximal brush border membrane. The impact on NaPi-IIa 
expression and regulation has been studied in knock-out mouse models for two 
members of the NHERF-family recently (see 3.5.1 and 3.5.2). In addition, 
expression in renal proximal tubules and co-localization with NaPi-IIa has been 
confirmed for some other PDZ-proteins also identified in this (and other) yeast-
two-hybrid screening. These include MAST205 (a 205 kDa microtubule-
associated serine/threonine kinase), CAL (CFTR-associated ligand), PDZ-
RGS3 (PDZ-containing regulator of G-protein coupled signaling 3), (S. Reining, 
unpublished observations) and Shank2E (SH3/ankyrin domain gene 2; splice 
variant E). The latter has been shown to undergo Pi-induced internalization 
similar to NaPi-IIa (McWilliams, Breusegem et al. 2005). 
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Figure 8: Summary of NaPi-IIa interacting proteins. 
 
 
3.5.1 NHERF1 
NHERF1 is a 50 kDa protein that is associated with the apical membrane 
of renal epithelial cells. It was first identified as a crucial adaptor component in a 
multiprotein complex that is required for PKA phosphorylation and inactivation 
of the sodium hydrogen exchanger NHE3 (Weinman, Minkoff et al. 2000). It is 
characterized by two tandem PDZ-domains and a C-terminal moesin-ezrin-
radixin-merlin (MERM)-binding domain. The first PDZ-domain mediates the 
interaction between NHERF1 and NaPi-IIa. The MERM-binding domain 
interacts with proteins of the MERM family, such as ezrin, and thus may link 
NaPi-IIa to the actin cytoskeleton (Reczek, Berryman et al. 1997). Ezrin also 
functions as an A kinase anchoring protein (AKAP) due to its ability to bind to 
the regulatory subunit of PKA.  
Disruption of the interaction between NaPi-IIa and NHERF1 leads to a 
reduced apical expression of NaPi-IIa in cells (Hernando, Deliot et al. 2002). 
Moreover, apical expression of NaPi-IIa is reduced in NHERF1-/- mice and the 
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cotransporter accumulates in intracellular vesicles. This is consistent with the 
mild renal Pi wasting phenotype that was observed in these animals 
(Shenolikar, Voltz et al. 2002). Surprisingly, NHE3 abundance in the apical 
membrane was not affected by the loss of NHERF1, suggesting that NHERF1 is 
important for apical positioning of some but not all interacting membrane 
proteins. Upregulation of NaPi-IIa in response to a low Pi diet is impaired in 
NHERF1-/- mice, a finding which is in line with a role of NHERF1 in apical 
scaffolding of NaPi-IIa (Weinman, Boddeti et al. 2003). 
In addition to its function as scaffolding protein, NHERF1 also plays an 
important role for the signaling cascade that leads to PTH-induced 
downregulation of NaPi-IIa. This is due to its ability to interact simultaneously 
with type I PTH-receptors (PTH1R) and PLCβ in a PDZ-dependent way. In most 
cells, PTH1R couples to Gs- or Gq-proteins. Coupling to Gs leads to an increase 
of adenylyl cyclase activity and a rise in cAMP which in turn activates PKA 
whereas coupling to Gq results in activation of PLC/PKC. However, in vitro 
studies with NHERF2, a protein with very similar properties to NHERF1, 
demonstrated that PTH couples to Gi/o-proteins when the PTH1R is bound to 
NHERF2. This particular subfamily of inhibitory G-proteins signal via activation 
of PLCβ  (by the βγ-subunits of the G-protein) and inhibition of adenylyl cyclase 
(by the α-subunit) (Mahon, Donowitz et al. 2002). Since NHERF1 is only 
present at the apical membrane, the described reaction could take place on the 
apical but not on the basolateral membrane. This would explain why signaling of 
basolateral PTH-receptors occurs via activation of PKA whereas the apical 
PTH-response is shifted towards PKC activation in renal proximal tubules    
(Fig. 3). Indeed it has been shown that stimulation of only apical PTH-receptors 
failed to induce internalization of NaPi-IIa in NHERF1-/- mice (Capuano, Bacic et 
al. 2007).  
Interestingly, activation of PKC and PKA leads to phosphorylation of 
NHERF1 itself and PTH causes a dissociation of the NaPi-IIa/NHERF1 complex 
in OK cells and murine kidney (Deliot, Hernando et al. 2005). In a recent 
publication, a serine residue located within the first PDZ-domain of NHERF1 
has been shown to be phosphorylated upon PKC and PKA activation. It has 
been proposed that phosphorylation of this residue may change the 
conformation of the whole PDZ-domain and thus reduces the binding affinity of 
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NHERF1 for NaPi-IIa (Weinman, Biswas et al. 2007). The “released” NaPi-IIa 
could be then internalized according to this model. 
In summary, NHERF1 is an important scaffolding protein that anchors 
NaPi-IIa in the apical membrane. Additionally, it also influences signaling events 
which lead to a membrane retrieval of NaPi-IIa. 
 
 
3.5.2 PDZK1 
PDZK1 (NHERF3) is a protein that consists of ~520 amino acids which 
form four tandem PDZ-domains. It is expressed in epithelial cells of the kidney, 
pancreas, liver, gastrointestinal tract and adrenal cortex (Kocher, Comella et al. 
1998). Renal expression is restricted to the proximal tubule where PDZK1      
co-localizes with NaPi-IIa in the brush border membrane.  
The C-terminal TRL-motif of NaPi-IIa has been shown to interact 
specifically with the third PDZ-domain of PDZK1 (Gisler, Pribanic et al. 2003). 
The fourth PDZ-domain of PDZK1 interacts with NHERF1. It has been 
suggested that PDZK1 is part of a network of proteins which are involved in 
trafficking, apical positioning and regulation of various transporters, receptors 
and components of signaling cascades (Gisler, Madjdpour et al. 2003; Gisler, 
Pribanic et al. 2003). Knock-out of PDZK1 did not impair renal Pi handling and 
NaPi-IIa membrane expression under normal dietary conditions. Acute dietary 
regulation as well as PTH-induced downregulation of NaPi-IIa was similar in 
PDZK1-/- compared to PDZK1+/+ mice. Only chronic feeding of PDZK1-/- mice 
with a high Pi diet reduced NaPi-IIa abundance in the apical membrane and 
increased urinary Pi excretion even further compared to PDZK1+/+ mice 
(Capuano, Bacic et al. 2005). The lack of a prominent phenotype for NaPi-IIa in 
PDZK1-/- mice could be due to compensation by other PDZ-proteins such as the 
closely related PDZK2 (NHERF4). Similar to PDZK1, PDZK2 consists of four 
PDZ-domains and is expressed in renal proximal tubules. Pull-down analysis 
and co-immunoprecipitation confirmed the interaction between NaPi-IIa and 
PDZK2. The C-terminal TRL-motif of NaPi-IIa and the third PDZ-domain of 
PDZK2 are the required molecular determinants for the interaction (S. Reining, 
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unpublished results). The precise physiological roles of PDZK1 and PDZK2 in 
the context of Pi homeostasis remain to be clarified. 
 
 
3.6 Advantage of a novel membrane yeast-two-hybrid system  
Classical yeast-two hybrid screenings relay on the reconstitution of 
transcription factor activity upon interaction between bait and prey. Therefore, it 
depends on nuclear transport of both bait and prey constructs. In practical terms 
this excludes the possibility to use full-length membrane proteins as bait. Indeed 
the three screenings mentioned above were performed using discrete 
intracellular domains of NaPi-IIa (N-terminus, third intracellular loop,                
C-terminus) as bait.  
More recently, a new yeast-two-hybrid approach has been developed 
allowing to studying interactions of full-length membrane proteins. This 
approach depends on the reconstitution of ubiquitin which is split in two halves 
(Fig. 9). One of the halves is fused to the bait whereas the other halve is fused 
to the prey. Upon bait-prey interaction, the two halves of ubiquitin are brought 
together and the transcription factor that is fused to the membrane protein of 
interest (bait) is cleaved and released by ubiquitin specific proteases. The free 
transcription factor enters the nucleus and activates the transcription of reporter 
genes (Gisler, Kittanakom et al. 2008). 
This new method was applied to search for additional NaPi-IIa interacting 
partners. In order to prevent PDZ-based interactions, a ΔTRL (instead of the 
full-length) NaPi-IIa construct was used as bait. This membrane                 
yeast-two-hybrid screening led to the identification of GABARAP as a new 
interacting partner of   NaPi-IIa. 
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Figure 9: Principle of the membrane yeast-two-hybrid screen. 
PM: plasma membrane; NubG: N-terminal half of the split ubiquitin containing a mutation from isoleucine 
to glycine which prevents self-reconstitution; Cub: C-terminal half of split-ubiquitin TF: transcription factor; 
UBPs: ubiquitin specific protases 
(modified from Gisler et al., Mol Cell Proteomics. Vol. 7, 2008) 
 
 
3.7 GABARAP 
GABARAP was originally identified as a GABAA-Receptor Associated 
Protein (Wang, Bedford et al. 1999). It has been shown later that expression of 
GABARAP is not restricted to the brain. Thus, GABARAP protein is also 
detected in kidney, liver, spleen, skeletal muscle and heart (Tanida, Ueno et al. 
2004) as well as in various human cell lines (Green, O'Hare et al. 2002). 
Regarding the subcellular localization of GABARAP, a punctate distribution 
within the cytoplasm has been reported in some breast epithelial cells, HeLa 
cells and neurons (Wang, Bedford et al. 1999; Kneussel, Haverkamp et al. 
2000; Green, O'Hare et al. 2002; Klebig, Seitz et al. 2005). 
Interestingly, GABARAP belongs to a family of proteins which are 
evolutionary highly conserved among eukaryotic species from yeast over plants 
to mammals (Coyle and Nikolov 2003). The sequence identity between human 
GABARAP and its mouse orthologue is 100%. In addition, several GABARAP-
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like homologues have been identified in human and in mouse (Sagiv, Legesse-
Miller et al. 2000; Vernier-Magnin, Muller et al. 2001; Xin, Yu et al. 2001), 
suggesting a critical function of this protein family.   
The GABARAP protein consists of 117 amino acids and has an 
asymmetric structure with a basic N-terminal region and an acidic C-terminus 
(Fig. 10). Amino acids 1-22 at the N-terminus potentially form an α-helix with 
five positively charged amino acids on one side of the helix. This motif has been 
shown to interact with tubulin and to promote tubulin assembly in vitro (Wang 
and Olsen 2000). The amino acids between residue 36 and 68 have been 
shown to mediate the interaction with the γ-subunit of GABAA-receptors (Wang, 
Bedford et al. 1999). In addition, GABARAP interacts with a variety of other 
receptors among them the transferrin receptor (Green, O'Hare et al. 2002) and 
the angiotensin II type 1 receptor (Cook, Re et al. 2008).  
GABARAP has been suggested to participate in membrane targeting 
and/or degradation processes. This hypothesis has been supported by the 
finding that GABARAP interacts with the N-ethylmaleimide-sensitive factor 
(NSF), a chaperone that activates SNARE proteins in membrane fusion events 
(Kittler, Rostaing et al. 2001) and also with the clathrin heavy chain (Mohrluder, 
Hoffmann et al. 2007). Furthermore, GABARAP interacts with gephyrin, a 
receptor-cytoskeleton linker that interacts with the glycine receptor and 
polymerized tubulin (Kneussel, Haverkamp et al. 2000).  
Originally, a role for GABARAP in the clustering of GABAA-receptors in 
postsynaptic membranes was proposed (Chen, Wang et al. 2000). Supporting 
this hypothesis is the finding that overexpression of GABARAP increased the 
cell-surface number of GABAA-receptors in cultured hippocampal neurons (Leil, 
Chen et al. 2004) and Xenopus laevis oocytes (Chen, Chang et al. 2007). 
However, the synaptic localization of GABAA-receptors is not affected in 
GABARAP-/- mice. A possible explanation for this finding could be the functional 
redundancy of GABARAP with the close related family members GABARAP-L1 
and GABARAP-L2 (O'Sullivan, Kneussel et al. 2005).  
Interestingly, the core-domain of GABARAP contains an ubiquitin-like 
fold (Bavro, Sola et al. 2002). It has been shown that GABARAP indeed 
undergoes a post-translational modification that resembles ubiquitylation. Thus, 
GABARAP is cleaved at G116, activated by E1- and E2-like enzymes and 
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finally conjugated to other molecules, most likely phospholipids (Tanida, 
Komatsu et al. 2003; Sou, Tanida et al. 2006). Insertion of lipopeptides into the 
membrane could also have an influence the membrane expression of proteins. 
In this regard, it has been proposed that NaPi-IIa activity and membrane 
abundance depends on its interactions with lipid microdomains (Breusegem, 
Halaihel et al. 2005). 
 
 
Figure 10: Cartoon diagram of the GABARAP three-dimensional backbone structure. 
Amino acids 1–35 are in green, amino acids 35–68 are in red, and amino acids 68–117 are in blue.  
The constructs used later in the GST-pull down experiments are amino acids 35–117 (colored in red and 
blue) and amino acids 1–68 (colored in green and red).  
(modified from Knight et al., Journal of Biological Chemistry Vol.277, 2002) 
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4. Aim of the work 
 
The Na-dependend Pi cotransporter NaPi-IIa is expressed in the brush 
border membrane of renal proximal tubules. Its function is to reabsorb Pi from 
the primary urine. The apical expression of NaPi-IIa is regulated by hormones 
and other factors such as the availability of Pi. Apical expression and regulation 
of NaPi-IIa is controlled by a network of interacting proteins. To identify novel 
interacting partners a membrane yeast-two-hybrid screening was performed 
using the functional NaPi-IIa cotransporter as bait. The C-terminal TRL-motif of 
NaPi-IIa was deleted in order to avoid the numerous interactions with PDZ-
proteins that have been shown and studied earlier. 
This approach led to the identification of GABARAP as a novel, putative 
interacting partner of NaPi-IIa. The first aim of my studies was to confirm the 
expression of GABARAP in renal proximal tubules and to verify the interaction 
between both partners in vitro.  
The generation of GABARAP-/- mice has made it possible to study the 
physiological role of the interaction between GABARAP and NaPi-IIa in vivo. 
Therefore, in the second part of my work, my aim was to investigate the effect 
of the absence of GABARAP on the steady state expression of NaPi-IIa, its 
hormonal regulation as well as chronic and rapid adaptation to different Pi diets.  
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5. Material and Methods 
 
5.1 Animal Studies 
GABARAP-/- mice were derived from a library (Omnibank) of embryonic 
stem cells in which various genes were inactivated by gene-trap methodology 
based on insertion of a huge viral vector (Zambrowicz, Friedrich et al. 1998). 
One of the clones was used to generate a heterozygous GABARAP mouse by 
blastocyst injection (Lexicon Pharmaceuticals, Texas, USA). GABARAP-/- mice 
were generated from transgenic 129SvEvBrd embryonic stem cells, injected 
into C57Bl/6J albino blastocyts and back crossed for 7 generations with the 
C57Bl/6J line. All experiments were performed with 12-16 weeks old mice.  
 
5.1.1 Genotyping of mice 
Genomic DNA was extracted from tail tissue of the mice. Briefly, ~2 mm 
tail tissue was dissolved in 500 µl lysis buffer containing 100 mM Tris-HCl pH 
8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl and 0.1 µg/µl proteinase K by over 
night incubation at 55 ºC. Undigested material was pelleted by centrifugation in 
a microfuge at full speed for 5 min. Genomic DNA was precipitated by adding 
500 µl isopropanol to the supernatant and inversion of the tube for ~20 times. 
The DNA was pelleted and subsequently washed with 70% EtOH. After 
washing, the pellet was dried and finally resuspended in 100 µl TE buffer 
containing 10 mM Tris-HCl pH 8 and 1 mM EDTA. 
For genotyping, 1 µl of the genomic DNA was used for each of the two 
PCRs. The two different sets of primers which were used are indicated below. 
The PCR was performed using the Taq-Polymerase (Sigma) and 35 cycles. The 
annealing temperature was either 60 °C (primer pair 1) or 64 °C (primer pair 2). 
Elongation time was 2 min in both PCR reactions. 
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Figure 11: Schematic model of the genotyping of GABARAP-/- mice. 
 
5.1.2 Animal treatments 
For metabolic studies, mice were housed separately in metabolic cages with 
free access to food and water. Urine was collected under mineral oil. Blood was 
withdrawn from the vena cava of anesthetized mice. Urinary and plasma ion 
composition was analyzed by Ion Chromatography (Metrohm 820 Professional 
IC). Creatinine and Pi concentrations were determined according to the Jaffe 
(Wako Chemicals) and Fiske Subarov methods (Sigma Diagnostics) 
respectively. Urinary concentration of cAMP was determined using a cAMP [3H] 
assay system (Amersham). 
For PTH-injections mice were injected i.p. with 0.5 µg/g body weight of   
1-34 PTH (Sigma) or with 0.9% NaCl as control. Kidneys were harvested        
45 minutes after injection and rapidly frozen until further use.  
For dietary adaptation, mice were fed either with a high (1.2%) or a low 
(0.1%) Pi diet (Kliba, NAFAG) and had free access to water. In order to study 
the acute effect of dietary Pi, the mice were trained to receive food only for        
4 hours daily to time food intake.  
All animal experiments were performed according to Swiss Animal 
Welfare laws, with approval of the local veterinary authority (Kantonales 
Veterinäramt Zürich). 
 
 
5.2 Plasmids 
To obtain GST-fusion constructs, PCR products encoding either full 
length or amino acids 1-68 and 36-117 of GABARAP were subcloned into the 
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BamHI/SalI site of pGEX-TK-Ras (Zhao, Lim et al. 2001). To generate myc-
fused GABARAP, nucleotide sequences encoding the myc epitope 
(EQKLISEEDL) immediately preceded by a Kozak consensus sequence were 
first introduced into the pcDNA3.1 plasmid (Invitrogen) by bi-directional PCR 
with overhanging primers followed by subsequent phosphorylation and ligation. 
Then, full-length GABARAP was subcloned into the myc-pcDNA3.1 plasmid 
using XhoI/KpnI restriction sites. Mouse NaPi-IIa was subcloned into the 
mammalian expression vector pHA-MEX (Dualsystems Biotech) using 
XhoI/EcoRI restriction sites. Generation of NaPi-IIa ΔL571 has been described 
elsewhere (Karim-Jimenez, Hernando et al. 2001). 
 
 
5.3 Expression of GST-fusion proteins in E.coli 
XL-1 blue competent cells were transformed with the respective plasmid 
by heat-shock and plated on a LB-agar plate (10 g/l Bacto tryptone, 5 g/l yeast 
extract, 10 g/l NaCl and 15 g/l agar) containing 100 µg/ml ampicillin. An 
overnight culture was set up in 50 ml LB medium supplemented with 2%         
D-glucose and 100 µg/ml ampicillin. The next day, 20 ml of this culture were 
diluted in 500 ml LB-medium containing D-glucose and ampicillin. The culture 
was further incubated at 37 ºC to an OD600 of 0.6 to 0.8. Then, isopropyl-1-thio-
β-D-galactoside (IPTG) was added to a final concentration of 1 mM. The 
incubation of the culture was continued for 14 hrs at 25 ºC. The bacteria were 
pelleted by centrifugation at 5000 g for 10 min at 4 ºC. The supernatant was 
discarded and the pellet was resuspended in 8 ml lysis buffer (Tris-HCl pH 8, 
120 mM NaCl, 0.5% Igepal CA-630, 5 mM DTT, 1 mM EDTA, 2 mg/ml 
lysozyme, 1 µg/ml leupeptin, 1 mM PMSF and Roche protease inhibitor 
cocktail). After 15 min on ice, the lysis of the bacteria was completed by 
sonication for 30 sec (pulsed, stage 3, 30% cycle) twice. The solubilized 
bacteria were centrifuged at full speed in a microfuge at 4 ºC for 15 min. The 
supernatants were shock frozen in liquid nitrogen and stored at -80 ºC until 
further usage. 
In order to estimate the amount of GST-fusion proteins in the bacteria 
lysates, glutathione agarose beads (Sigma) were equilibrated in buffer I 
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containing 50 mM Tris-HCl pH 8, 120 mM NaCl, 0.5% Igepal CA-630 and 5 mM 
DTT. After a short centrifugation, 250 μl of the same buffer and 50 μl E.coli 
extract were added to the beads. The mixture was then incubated for 60 min at 
4 °C on a rotary shaker. Next, the beads were washed twice with 500 μl buffer I 
containing 0.075% SDS. Proteins were eluted by incubation in 50 µl loading 
buffer at 95 °C for 5 min. Samples (25 µl) were subsequently analyzed on a 
SDS-PAGE with BSA standards of known protein concentration. After 
completing electrophoresis, the gel was stained with Coomassie blue and the 
protein concentration of the GST-proteins was estimated.  
 
 
5.4 Preparation of brush border membrane vesicles (BBMV) 
BBMV were prepared using the Mg2+-precipitation technique (Biber, 
Stieger et al. 2007). Kidneys were cut into small pieces in a glass petri dish on 
ice and transferred into 800 μl ice-cold homogenization buffer containing       
300 mM mannitol, 5 mM EGTA and 12 mM Tris-HCl, pH 7.1. Then, the kidneys 
were homogenized for 2 min on ice using a polytron (Kinematica). Upon 
addition of 1120 μl water and 22 μl of 1M MgCl2 (12 mM final) samples were 
precipitated on ice for at least 15 min.  
Scraped mucosa of the ileum of the small intestine was mixed with 200 μl 
ice-cold homogenization buffer and 1000 μl of water and then homogenized 
using an Omnimixer at speed 5 for 1 min. Samples were transferred into an 
eppendorf tube and 11 μl of 1M MgCl2 (10 mM final) was added. BBM were 
precipitated on ice for at least 30 min. 
Then, the samples (from kidney/intestine) were centrifuged in a Sorvall 
centrifuge (rotor SS34) for 15 min at 4500 rpm. Small aliquots of supernatants, 
representing total homogenates, were immediately frozen, whereas the rest 
was further centrifuged at 18500 rpm for 30 min. The pellet was resuspended in 
1 ml of membrane buffer (300 mM mannitol, 20 mM Hepes-Tris, pH 7.4) and 
centrifuged again at 18500 rpm for 30 min. After removing the supernatant, the 
pellet containing the BBMV was resuspended in 150 μl of membrane buffer. 
Finally, protein concentration was measured using a BioRad protein 
determination kit (Lowry method).  
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5.5 Glutathione S-Transferase Pull-Downs 
GST pull-downs were performed with isolated BBM or HEK293 cell 
lysates. In order to couple GST-protein to Glutathione agarose-beads (Sigma), 
40 µl beads were equilibrated in 1 ml buffer I (see 5.4). After a short 
centrifugation step (~10 sec in a microfuge) the supernatant was sucked off the 
beads and 250 µl buffer I was added. E.coli extract containing 50 µg GST-
fusion protein (see 5.4) was added to the beads and the mixture was incubated 
at 4 ºC for at least 1 hr on a rotary shaker. Next, the beads were washed three 
times either with buffer I and once either with DB-buffer (20 mM Tris-HCl pH 8, 
100 mM NaCl, 5 mM EDTA, 10% sucrose, Roche protease inhibitor cocktail) 
when BBMV were used or with cell lysis buffer (20 mM Tris-HCl pH 8, 100 mM 
NaCl, 5 mM EDTA, 10% sucrose, 0.75% Triton X-100, 0.75% Na-deoxycholate, 
Roche protease inhibitor cocktail) for pull-downs from transfected cells. 
  For GST-pull downs from BBMV, the membranes were first solubilized 
as follows: 50 µg BBMV were diluted in SB-A buffer (20 mM Tris-HCl pH 8,        
5 mM EDTA, 10% glycerol, 1 mM PMSF, 5 µg/ml leupeptin, 5 µg/ml pepstatin 
A) in a final volume of 50 µl. Then, 50 µl SB-A containing 1% Na-deoxycholate 
was added and mixed gently by pipetting. After incubation for 1 hr at room 
temperature, undissolved membranes were removed by centrifugation at full 
speed in a microfuge at 4 ºC for 30 min. The supernatant was added to the 
GST-coupled beads which were resuspended in 1.2 ml DB-buffer after the 
washings. 
 For GST-pull downs from transfected HEK293 cells, cultures (10 cm 
dish) were lysed in 1.2 ml cell lysis buffer and incubated on ice for 15 min. 
Then, lysates were passed 10 times through a syringe with a 25G needle. 
Cellular debris was removed by centrifugation at full speed in a microfuge for  
30 min at 4 ºC. 35 µl Glutathione agarose beads were equilibrated in cell lysis 
buffer and added to the supernatants. After preclearing for 1 hr at 4 ºC on a 
rotary shaker, beads were pelleted by short centrifugation and the cell lysates 
were added to the GST-coupled beads.  
GST-coupled beads were incubated on a rotary shaker over night at 4 °C 
with solubilized BBM or cell lysate. Then, samples were centrifuged at 13000 g 
for 1 min. The pelleted beads were washed 5-6 times with TBS containing 0.1% 
(v/v) Nonidet P-40 and 0.1% (v/v) Tween 20. Proteins were eluted by incubation 
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in 50 µl loading buffer at 95 °C for 5 min. Samples (25 µl) were subsequently 
analyzed by Immunoblot. 
 
 
5.6 Immunoblots 
Kidney homogenates or renal BBM were prepared as described before 
(see 5.5). For Immunoblot analysis, samples obtained from GST-pull downs and 
co-immunoprecipitation as well as kidney homogenate (40 µg) and 
renal/intestinal BBM (15 µg) were separated on 9% SDS/PAGE gels, 
transferred to PVDF membranes and then incubated over night  at 4 °C with 
antibodies against NaPi-IIa (Custer, Lotscher et al. 1994), NaPi-IIc (Nowik, 
Picard et al. 2008), PDZK1 (Gisler, Stagljar et al. 2001), NHERF-1 (Abcam), 
GABARAP (Green, O'Hare et al. 2002) and β-actin (Sigma). After incubation 
with HRP-linked secondary antibodies (GE Healthcare), immunoreactive signals 
were detected by chemiluminescence (ECL, Amersham Pharmacia Biotech) 
using the DIANA III-chemiluminescence detection system (Raytest). The 
densitometry of all images was analyzed using appropriate software (Advanced 
Image Data Analyser AIDA, Raytest) to calculate, for each given experiment, 
the ratio between the protein of interest to β-actin.  
 
 
5.7 Cell culture  
HEK293 cells were plated in 10 cm dishes and cultured in DMEM 
supplemented with 10% FCS, 5 mM L-Glutamine, 100 U/ml penicillin and      
100 U/ml Streptomycin in 5% CO2 at 37 °C. Subconfluent cultures were 
transfected with 6 µg plasmid using Lipofectamine 2000 (Invitrogen) according 
to the manufacturer`s instructions. All experiments were performed 48 hrs after 
transfection. 
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5.8 Co-Immunoprecipitation 
Two days after transfection cells were lysed in 1 ml IP-buffer containing 
50 mM Tris pH 7.4, 72 mM NaCl, 0.75% Triton X-100, 0.75% Na-deoxycholate, 
1 mM PMSF, 5 µg/µl Leupeptin, 5 µg/µl Pepstatin A. After pre-clearing with     
40 µl Protein G Plus/ Protein A agarose beads (Calbiochem) the anti-myc 
antibody (Invitrogen) was added in a dilution of 1:250. After incubation at 4 ºC 
on a rotary shaker over night, 50 µl Protein A/G beads were added to the 
lysates and further incubated at 4 ºC on a rotary shaker for 60 min. Protein G 
Plus/ Protein A agarose beads were pelleted by short centrifugation steps 
(microfuge) and washed 4 times with IP-buffer containing detergents and once 
with IP-buffer without detergents. Proteins were eluted by incubation in loading 
buffer at 95 °C for 5 min. Samples were subsequently analyzed by Immunoblot. 
 
 
5.9 Uptake in isolated BBMV 
The Na+-dependent transport rate of 32Pi into renal BBMV was 
determined in the presence of 0.1 mM potassium phosphate as described 
previously (Biber, Stieger et al. 1981). Briefly, 10 µl BBMV were added to 40 µl 
solution A for sodium-dependent transport (100 mM Mannitol, 20 mM HEPES-
Tris pH 7.4, 125 mM NaCl, 0.125 mM Pi pH7.4) or solution B to measure 
sodium-independent transport (100 mM Mannitol, 20 mM HEPES-Tris pH 7.4, 
125 mM KCl, 0.125 mM Pi pH 7.4). 40 µl of each solution (A or B) contained    
1-2 µCi 32P (as orthophosphoric acid). Transport of 32P was determined at       
25 ºC. To terminate the reaction after the desired time point (30 sec, 1 min,   
120 min), 20 µl of solution A or solution B containing the BBMV were pipetted 
into 1 ml ice-cold Stop-solution consisting of 100 mM Mannitol, 150 mM NaCl,  
5 mM Tris-HCl pH 7.4, 5 mM Pi pH 7.4. After vortexing, the sample was spotted 
onto a membrane (Sartorius) placed on a vacuum pump system. Then the 
membrane was washed with ~6 ml Stop-solution and put into a scintillation vial 
for counting.  
Similar protocols were used to measure uptake of radioactively labeled  
L-Glutamine and D-Glucose.  
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5.10 RNA Isolation and Real-Time PCR 
Total RNA was extracted from kidneys homogenized in RLT buffer using 
the RNeasy Mini Kit (Qiagen). Similarly, RNA from dissected nephron segments 
was extracted using the RNeasy Micro Kit (Qiagen) according to manufacturer`s 
instructions. Either 300 ng of RNA from total kidney or 80 ng of RNA from 
nephron segments were used as template for reverse transcription using 
TaqMan Reverse Transcription Kit (Applied Biosystems). Real-Time PCR was 
performed on the ABI PRISM 7700 Sequence Detection System, using 
commercial primers and probes for NHERF1 and GABARAP (Taqman Gene 
Expression Assays) as well as primers and probes for NaPi-IIa and NaPi-IIc 
(Madjdpour, Bacic et al. 2004) and β-ENaC (Fakitsas, Adam et al. 2007). 
Amplification was carried out using the TaqMan Universal PCR Master Mix 
(PCR machine and reagents from Applied Biosystems). The expression of the 
gene of interest was calculated in relation to hypoxanthine guanine 
phosphoribosyl transferase (HPRT). Relative expression ratios were calculated 
as R = 2[Ct(HPRT)-Ct(test gene)], where Ct represents the cycle number at the 
threshold 0.2. 
 
 
5.11 Immunostainings 
Mouse kidneys were perfusion-fixed through the right ventricle with a 
fixative solution containing freshly made 3% paraformaldehyde, 3 mM MgCl2, 
4.5 mM picric acid in a 6:4 mixture of 0.1 M cacodylate buffer (pH 7.4; adjusted 
to 300 mOsm with sucrose) and 10% hydroxyethyl starch (HAES). Subsequent 
immunohistochemistry was performed as described previously (Dawson, 
Gandhi et al. 1989). Briefly, cryosections (6 μm) were taken and pretreated with 
0.1% SDS (NaPi-IIa and NaPi-IIc) or 0.5% SDS (NHERF1/2 and 4F2) for 5 min 
followed by three washes in PBS for 5 min each. After blocking with 2% BSA, 
0.02% Na-azide in PBS, sections were incubated at 4°C overnight with 
antibodies against NaPi-IIa 1:600 (Custer, Lotscher et al. 1994), NaPi-IIc 1:400 
(Nowik, Picard et al. 2008), NHERF1/2 1:300 (Capuano, Bacic et al. 2005) and 
CD98 (4F2) 1:200 (Santa Cruz) in blocking solution. After three washings in 
PBS for 5 min each, binding sites of the primary antibodies were detected using 
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Alexa 488-conjugated anti-rabbit/Alexa 568-conjugated anti-goat antibodies 
(Invitrogen). F-actin was visualized using Texas-Red-coupled phalloidin which 
was added in a dilution of 1:100 (Invitrogen). The sections were washed again 
three times in PBS for 5 min each washing and then mounted with mounting 
medium (DACO). Sections were analyzed with an inverted epi-fluorescence 
microscope (Nikon Eclipse TE300). 
 
 
5.12 Determination of mineral concentrations in bone ashes 
The concentration of Pi and Ca2+ in lumbar vertebrae (L3 and L4) and 
femurs was determined as follows. Bones were extracted from the mice and 
frozen at -20 °C until further use. Then, the bones were first dried for 96 hrs at 
105 °C and afterwards put in a muffle furnace at 600 °C for 96 hrs to obtain 
bone ash. The ashes were resuspended in 8% HCl and then filtered. The 
minerals were determined by colorimetry with an autoanalyzer (COBAS MIRA, 
Roche) using commercial kits. Analyses of Pi and Ca2+ were based on the the 
phosphomolybdate and the methylthymol blue method, respectively (Liesegang, 
Loch et al. 2005). 
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6. Results 
 
6.1 Renal Expression of GABARAP and interaction with NaPi-IIa 
Using a classical yeast-two hybrid (YTH) screen, we previously identified 
several proteins that interact with the C-terminal intracellular tail of NaPi-IIa 
(Gisler, Stagljar et al. 2001). Most of these interactions were PDZ-based and 
depended on the last 3 residues of NaPi-IIa (TRL). Classical YTH analysis 
requires soluble baits to screen for protein-protein interactions. In comparison, 
the advantage of the split-ubiquitin membrane YTH system (MYTH) is that full-
length integral membrane proteins can be used as baits (Stagljar, Korostensky 
et al. 1998; Gisler, Kittanakom et al. 2008).  We used the MYTH 2.0 system to 
screen a mouse kidney library targeting the identification of interactions 
independent on the C-terminal PDZ-binding domain of NaPi-IIa. To this end, we 
used the TRL-truncated (instead of full-length) cotransporter as bait. Three 
interacting clones were identified as GABARAP. Two of these clones contained 
the full length open reading frame (ORF), whereas the third cDNA was a partial 
fragment that lacked the first 34 nucleotides of the ORF. The GABARAP protein 
consists of 117 amino acids and shares similarity with the light chain-3 of 
microtubule-associated proteins 1A and 1B (Wang, Bedford et al. 1999). 
 
6.1.1 Expression of GABARAP in the kidney 
Expression of GABARAP was first verified using RT-PCR from total 
kidney RNA with primers spanning intron-exon boundaries (data not shown). To 
further address the distribution of GABARAP mRNA within the kidney,        
Real-Time PCR was performed on dissected murine nephron segments. 
GABARAP mRNA was found to be uniformly expressed in all tested nephron 
segments (Fig. 12A).  
To rule out cross-contaminations with mRNA from different nephron 
segments, I analyzed the profile of known marker genes differentially expressed 
along the nephron. As marker for proximal tubules, NaPi-IIa expression was 
determined in the nephron segments. NaPi-IIa mRNA was highly abundant in 
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proximal convoluted tubules (S1+2) and expressed to a lesser extend in 
proximal straight segments (S3) whereas expression in more distal segments 
was hardly detectable (Fig. 12B). As a marker for distal nephron segments, I 
determined the expression of β-ENaC mRNA which was highly abundant in our 
preparation of CCD and absent in proximal segments (Fig. 12B).   
In order to confirm GABARAP protein expression, an Immunoblot using 
an antibody raised against human GABARAP (Green, O'Hare et al. 2002) was 
performed on murine renal BBM preparations (Fig. 12C). In addition to the band 
at the expected molecular weight of 17 kDa (Wang, Bedford et al. 1999), I 
observed a second product of faster mobility which most likely represents a 
lipidated form of GABARAP (Tanida, Ueno et al. 2004). None of these bands 
were detected in BBM preparations of GABARAP-/- mice, confirming the 
specificity of the signal. 
 
 
Figure 12: Renal expression of GABARAP mRNA and protein.  
Quantification of (A) GABARAP and (B) NaPi-IIa and β-ENaC mRNAs in dissected nephron segments. 
The abundance of GABARAP, NaPi-IIa and β-ENaC mRNA was measured by Real-Time PCR. Values 
were normalized to Hypoxanthine-guanine phosphoribosyltransferase (HPRT) (n=2). For NaPi-IIa and β-
ENaC, the highest value was set as 1 and used to normalize the other values. (C) Immunoblot analysis to 
detect the presence of GABARAP in renal BBM. BBM isolated from GABARAP-/- mice were used to show 
specificity of the antibody. 
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6.1.2 Interaction between NaPi-IIa and GABARAP 
The interaction of GABARAP and NaPi-IIa was verified by pull-downs of 
NaPi-IIa from BBM using GST-GABARAP and by co-immunoprecipitation from 
transfected HEK293 cells. In the pull-down assay, a band at the expected 
molecular weight for NaPi-IIa was detected using GST-GABARAP but not with 
GST alone (Fig. 13A). In addition, I tested two overlapping halves of GABARAP 
(aa 1-68 and aa 37-117, respectively) for their ability to interact with NaPi-IIa. 
As shown in figure 13A, both GST-fusion proteins were capable of pulling down 
NaPi-IIa from BBM. In the lower panel, a Ponceau staining of the membrane is 
shown to demonstrate the use of similar amounts of the GST-fusion proteins in 
the different pull downs.  
The specific interaction between NaPi-IIa and GABARAP was further 
confirmed by co-immunoprecipitation of myc-tagged GABARAP and NaPi-IIa 
from transfected HEK293 cells (Fig. 13B). Cells were transfected either with 
NaPi-IIa alone or cotransfected with NaPi-IIa and myc-GABARAP. Then, an 
antibody against the myc-epitope was used to immunoprecipitate myc-
GABARAP. A band with the expected molecular weight for NaPi-IIa was seen 
only in the immunoprecipitation from cotransfected cells in the presence of myc-
antibody (Fig. 13B top panel) but not in negative controls lacking either myc-
GABARAP or the anti myc-antibody. As expected, myc-GABARAP was not 
immunoprecipitated in both negative controls as demonstrated by immunoblots 
using an anti-myc antibody (Fig. 13B middle panel). Immunoblots on total cell 
lysates verified the expression of NaPi-IIa and myc-GABARAP in these 
experiments (Fig. 13B lower panel). 
A recent report proposes a consensus sequence for GABARAP-binding 
sites build around a highly conserved tryptophan residue (Thielmann, Mohrluder 
et al. 2008). The C-terminal intracellular tail of NaPi-IIa contains a sequence 
that would fit to this motif. In order to study whether this C-terminal sequence 
can mediate the interaction with GABARAP, pull downs were performed with 
lysates from HEK293 cells transfected either with the full length or a C-terminal 
truncated cotransporter (Δ571). As shown in the top panel of figure 13C, GST 
alone did not pull down the full length NaPi-IIa whereas both the full length and 
the truncated NaPi-IIa were pulled down by GST-GABARAP. The Ponceau 
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staining of the membrane is shown to demonstrate equal loading of the beads 
with GST-fusion proteins (Fig. 13C, middle panel). Overexpression of NaPi-IIa 
and NaPi-IIa Δ571 is demonstrated by Immunoblot analysis on total cell lysates 
(Fig. 13C, lower panel). 
 
 
Figure 13: Interaction between NaPi-IIa and GABARAP. 
(A) GST-Pull down analysis to show interaction between GABARAP and NaPi-IIa. Full length and 
overlapping halves of GABARAP were used to pull down NaPi-IIa from BBM. The top panel shows an 
Immunoblot probed with an anti-NaPi-IIa antibody. The lower panel shows the Ponceau staining of the 
PVDF-membrane (as grayscale figure) to demonstrate that similar amounts of GST and its fusion proteins 
were used in the different pull downs. (B) Co-immunoprecipitation of NaPi-IIa with myc-GABARAP from 
cotransfected HEK293 cells. Immunoblots of the immunoprecipitated material (top panels) and HEK293 
cell lysates (lower panels) were probed with anti-NaPi-IIa (upper blot) or anti-myc (lower blot) antibodies. 
(C) GST-Pull downs on lysates from HEK293 cells transfected with full length or truncated NaPi-IIa. The 
top panel shows an Immunoblot of the pulled down material probed with the NaPi-IIa antibody. As negative 
control, full length NaPi-IIa was incubated with GST (first lane). The middle panel shows the Ponceau 
staining of the PVDF-membrane (as grayscale figure). The lowest panel shows an Immunoblot on HEK293 
cell lysates probed with the NaPi-IIa antibody. 
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In a further attempt to identify the molecular determinant for the 
interaction within NaPi-IIa, I fused several discrete intracellular domains of 
NaPi-IIa to GST in order to pull down GABARAP from transfected HEK293 
cells. However, under similar conditions to the ones used in the pull-down 
experiments described above, I was unable to detect interaction between both 
partners (data not shown). The failure of these discrete domains of NaPi-IIa to 
associate with GABARAP could be due either to the need of more than one 
single intracellular loop for the association or to the requirement of more 
physiological conditions. 
 
 
6.2 Analysis of GABARAP-/- mice under normal conditions 
6.2.1 Metabolic cage studies with GABARAP+/+ and GABARAP-/- mice 
In metabolic cage studies, I found that GABARAP-/- mice were slightly 
though significantly heavier than GABARAP+/+ despite the fact that both groups 
consume similar amounts of food (Table 1). In addition, GABARAP-/- animals 
drank less water which translated in a reduced urinary output. The reduced 
urinary excretion tightly correlates with the increased osmolarity and creatinine 
concentration in the urine from GABARAP-/- animals. Urinary pH as well as 
urinary cAMP levels were similar in both groups.  
Interestingly, the urinary excretion of Pi (as a ratio to creatinine) was 
significantly reduced in GABARAP-/- as compared to GABARAP+/+ mice, 
whereas excretion of all other tested ions (Cl-, Na+, K+, Mg2+ and Ca2+) was 
similar in both groups when normalized to urinary creatinine (Table 1).  
Despite the reduced urinary Pi excretion in GABARAP-/- mice, the 
concentration of Pi in serum did not differ between both groups (Table 1). The 
Ca2+ concentration in blood was also similar in both groups of animals whereas 
the circulating levels of Cl-, Na+ and K+ were all increased in GABARAP-/- as 
compared to GABARAP+/+ mice. 
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Table 1: Metabolic cage studies and urine/blood analysis of GABARAP-/- and GABARAP+/+ mice.  
Values are means ± SEM with either n=15 mice per group (for metabolic cage data and urine analysis) or 
n=10 mice per group (for blood analysis). (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.0001, unpaired student t-test) 
 GABARAP+/+ GABARAP-/- 
Metabolic cages   
  Body weight (g) 28.48 ± 0.56 30.53 ± 0.34 ** 
  Food intake (mg / g body weight) 0.137 ± 0.005 0.148 ± 0.004 
  Water intake (ml / g body weight) 0.203 ± 0.010 0.170 ± 0.009 * 
  Stool (g / g body weight) 0.052 ± 0.004 0.052 ± 0.003 
  Urine (ml / g body weight) 0.059 ± 0.006 0.041 ± 0.002 ** 
Urine chemistry   
   pH 6.10 ± 0.04 6.15 ± 0.08 
   Osmolality (mosm/kg H2O) 2494 ± 164 3634 ± 124 *** 
   Creatinine (mg/dl) 59.28 ± 4.28 94.96 ± 5.93 *** 
   cAMP (pmol) / creatinine (mg/dl) 25.14 ± 0.91 23.68 ± 0.68 
   Na+ (mM) / creatinine (mg/dl) 1.95 ± 0.11 1.80 ± 0.10 
   K+ (mM) / creatinine (mg/dl) 7.15 ± 0.23 7.02 ± 0.38 
   Ca2+ (mM) / creatinine (mg/dl) 0.037 ± 0.009 0.032 ± 0.003 
   Mg2+ (mM) / creatinine (mg/dl) 0.62 ± 0.02 0.56 ± 0.03 
   Pi (mM) / creatinine (mg/dl) 1.79 ± 0.07 1.24 ± 0.09 *** 
   Cl- (mM) / creatinine (mg/dl) 5.13 ± 0.38 4.32 ± 0.24 
Blood chemistry   
   Na+ (mM) 143.3 ± 0.33 146 ± 0.86 ** 
   K+ (mM) 3.84 ± 0.09 4.39 ± 0.18 * 
   Ca2+ (mM) 1.28 ± 0.01 1.27 ± 0.01 
   Pi (mM) 2.54 ± 0.06 2.66 ± 0.14 
   Cl- (mM) 110.5 ± 0.45 112.1 ± 0.64 * 
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6.2.2 NaPi-IIa and NaPi-IIc expression in GABARAP+/+ and GABARAP-/- 
mice  
NaPi-IIa is the major regulator of renal Pi handling and the absence of 
the NaPi-IIa interacting partner GABARAP results in a reduced urinary excretion 
of Pi (Table 1). Therefore, I next studied whether the interaction with GABARAP 
has an influence on NaPi-IIa expression. For that purpose I performed 
Immunoblot analysis on BBM isolated from GABARAP+/+ and GABARAP-/- mice. 
In these experiments, β-actin was used as loading control and to normalize the 
expression levels. NaPi-IIa abundance was increased approximately two-fold in 
renal BBM of GABARAP-/- as compared to GABARAP+/+ mice (Fig. 14A). The 
expression of a second Na-dependent Pi cotransporter, NaPi-IIc, was similar in 
both groups (Fig. 14B).  
As a next step I analyzed whether the difference in NaPi-IIa protein 
abundance involves changes on the transcriptional level. Therefore, I quantified 
the amount of NaPi-IIa mRNA in kidneys from GABARAP+/+ and GABARAP-/- 
mice by Real-Time PCR. As shown in figure 14C both groups of animals had 
similar levels of NaPi-IIa mRNA, suggesting that upregulation of the 
cotransporter in GABARAP-/- mice is independent on transcriptional changes. In 
addition, NaPi-IIc mRNA expression was compared between GABARAP+/+ and 
GABARAP-/- mice and its levels were similar in both groups. 
Immunohistochemistry was performed to determine whether the loss of 
GABARAP alters the segmental and/or subcellular distribution of NaPi-IIa. In 
addition the pattern of expression of NaPi-IIc was also analyzed. It has been 
shown earlier that NaPi-IIa expression is highest in proximal convoluted tubules 
(S1, S2) and gradually decreases towards the end of the proximal straight 
tubule (S3) with a decreasing gradient from juxtamedullary to superficial 
nephrons (Custer, Lotscher et al. 1994). In adults, NaPi-IIc expression is found 
preferentially in S1 segments of proximal convoluted tubules of juxtamedullary 
nephrons (Segawa, Kaneko et al. 2002; Ohkido, Segawa et al. 2003). As shown 
in figures 15A and B, the segmental distribution and subcellular localization of 
NaPi-IIa and NaPi-IIc were not altered in kidneys from GABARAP-/- as 
compared to GABARAP+/+ mice.  
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Figure 14: Expression of NaPi-IIa and NaPi-IIc protein and mRNA in GABARAP-/- and GABARAP+/+ 
mice. 
 
Immunoblot on renal BBM isolated from GABARAP+/+ and GABARAP-/- mice to analyze the expression of 
(A) NaPi-IIa and (B) NaPi-IIc. Expression of both transporters was normalized to the abundance of β-actin 
for the quantification. (C) Real-Time PCR to determine mRNA levels of NaPi-IIa (left) and NaPi-IIc (right) 
on mRNA extracted from kidney. NaPi-IIa and NaPi-IIc mRNA expression was normalized to HPRT (n=6). 
Data are means ± SEM. (** p ≤ 0.01, unpaired student t-test). 
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Figure 15: Immunohistochemical analysis of NaPi-IIa and NaPi-IIc in GABARAP+/+ and GABARAP-/- 
mice. 
 
Immunostaining of (A) NaPi-IIa and (B) NaPi-IIc on kidney cryosections obtained from GABARAP+/+ (left) 
and GABARAP-/- mice (right). Renal cortical overviews are displayed as grayscale figure. The images of 
single proximal tubules show (A) NaPi-IIa and (B) NaPi-IIc, both green, co-stained with β-actin (red) as a 
marker for BBM.  
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6.2.3  Pi transport activity into BBMV from GABARAP+/+ and GABARAP-/- 
mice  
In order to test whether the increased amount of NaPi-IIa in GABARAP-/- 
mice also translates into an increased Pi transport acitvity, I measured         
Na+-dependent uptake of 32Pi into BBMV. As shown in figure 16, Na-dependent 
uptake of Pi was significantly higher in BBMV prepared from GABARAP-/- as 
compared to GABARAP+/+ mice. As a control, uptake of L-glutamine and         
D-glucose into the same preparations of BBMV was determined (Fig. 16). The 
lack of GABARAP specifically upregulates Na+/Pi-cotransport in BBM since   
Na+-dependent uptake of L-Glutamine and D-Glucose were both not altered. 
The effect observed in the transport studies is smaller than the increase on the 
expression of NaPi-IIa in GABARAP-/- mice seen in Immunoblots (Fig. 14A). 
This is likely due to the presence of other Na+-dependent Pi cotransporters, 
such as NaPi-IIc, which also contribute to the Na+/Pi-uptake in renal BBM.  
 
 
Figure 16: Na+-dependent uptake into renal BBMV.  
 
Na+-dependent uptake of Pi (n=10), L-Glutamine (n=4) and D-Glucose (n=5) into BBMV isolated from 
kidneys of GABARAP-/- and GABARAP+/+. Uptakes were analyzed after 1 minute incubation as indicated. 
Data are means ± SEM. (* p ≤ 0.05, unpaired student t-test) 
 
 
50 
 
6.2.4 Expression of known NaPi-IIa interacting proteins in GABARAP-/- 
mice 
I next analyzed whether the increased expression of NaPi-IIa in the BBM 
of GABARAP-/- mice is associated with changes in known NaPi-IIa interacting 
proteins. My interest was focused especially on the well studied members of the 
NHERF-family, namely NHERF1 and PDZK1. As shown in figure 17A, the 
abundance of NHERF1 was dramatically increased in kidney homogenates of 
GABARAP-/- as compared to GABARAP+/+ mice. Most likely, the products of 
different mobility in SDS-gels represent distinctly phosphorylated NHERF1. In 
contrast to NHERF1, the expression of PDZK1 was similar in both groups 
based on immunoblot data. 
In order to determine whether the upregulation of NHERF1 protein is due 
to an increased gene expression, I performed RealTime PCR for NHERF1 on 
total kidney RNA from GABARAP+/+ and GABARAP-/- mice. As for NaPi-IIa, 
upregulation of NHERF1 is independent on changes at the transcriptional level, 
since NHERF1 mRNA abundance was not altered in GABARAP-/- mice (Fig. 
17B).  
Surprisingly, no change of NHERF1 signal intensity or subcellular 
localization could be detected in immunofluorescence stainings of kidney 
cryosections obtained from GABARAP+/+ and GABARAP-/- mice (Fig. 17C). Of 
note, different antibodies were used for the immunoblots (Fig. 17A) and 
immunofluorescence (Fig. 17C) experiments. Immunoblots were performed with 
a commercial antibody that specifically recognizes NHERF1. However, this 
antibody failed to give a specific signal in immunostainings. Therefore, a 
different antibody had to be used in the immunofluorescence studies. The 
failure to detect NHERF1 changes between kidney cryosections from 
GABARAP-/- and GABARAP+/+ mice could be due to crossreaction of this 
second antibody with the NHERF2 isoform. 
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Figure 17: Renal expression of NHERF1 and PDZK1 in GABARAP-/- and GABARAP+/+ mice.  
(A) Immunoblot analysis of NHERF1 and PDZK1 on homogenates of kidneys extracted from GABARAP+/+ 
and GABARAP-/- mice. For quantification, expression was normalized to β-actin. (B) Real-Time PCR to 
determine NHERF1 mRNA levels normalized to HPRT (n=6). Data are means ± SEM. (** p ≤ 0.01, 
unpaired student t-test)  (C) Immunostaining of NHERF1 on kidney cryosections obtained from 
GABARAP+/+ (left) and GABARAP-/- mice (right). Renal cortical overviews are displayed as grayscale 
figure. The images of single proximal tubules show NHERF1 (green) and CD98/4F2 (red) as marker for 
proximal tubules. 
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6.2.5 Expression of NaPi-IIb in the small intestine 
Despite the increased renal Pi reabsorption in GABARAP-/- mice 
compared to GABARAP+/+ animals, serum Pi levels are similar in both groups 
(Table 1). Therefore, a compensatory mechanism must exist to balance Pi 
levels in the absence of GABARAP. Up to now, NaPi-IIb is the only NaPi 
cotransporter with a clear implication in intestinal absorption of Pi, and its 
expression in mice is known to be higher in the ileum than in other intestinal 
segments. To address whether a lower Pi absorption in the small intestine could 
mediate the compensatory effect, I analyzed the expression of NaPi-IIb in BBM 
prepared from scraped mucosa of the ileum. Again, β-actin was used as loading 
control and to normalize NaPi-IIb expression levels. The immunoblot data 
suggest that NaPi-IIb abundance is decreased in the small intestine of 
GABARAP-/- compared to GABARAP+/+ mice (Fig. 18).  
 
Figure 18: Expression of NaPi-IIb in BBM of the small intestine.  
Immunoblot on BBM isolated from the ileum of GABARAP+/+ and GABARAP-/- mice to analyze the 
expression of NaPi-IIb. Expression of NaPi-IIb was normalized to the abundance of β-actin for the 
quantification. 
 
 
6.2.6 Pi and Ca2+ content in the bones of GABARAP+/+ and GABARAP-/- 
mice 
As described before, in addition to the kidney and the intestine, bone 
formation and resorption also plays an important role in the overall Pi (and also 
Ca2+) homeostasis. A higher deposition of Pi in the bone could also contribute 
to the absence of hyperphosphatemia in the GABARAP-/- mice. Therefore, I 
analyzed the Pi and Ca2+ content in bones (femur as well as lumbar vertebrae 
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L3 and L4) from GABARAP+/+ and GABARAP-/- mice. As shown in figure 19, the 
Pi and the Ca2+ content was similar in lumbar vertebrae and in femurs of 
GABARAP+/+ and GABARAP-/- mice.  
  
 
Figure 19: Pi and Ca2+ content of the bones of GABARAP+/+ and GABARAP-/- mice. 
Bone ashes were obtained from the lumbar vertebras L3 and L4 as well as from the femurs of 2 
GABARAP+/+ and 2 GABARAP-/- mice. Pi and Ca2+ content were determined by colorimetric assays. Each 
column represents either L3+L4 or the femur of one animal.  
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6.3 Regulation of NaPi-IIa in GABARAP-/- mice 
6.3.1 PTH-induced internalization in GABARAP-/- mice 
To test whether the downregulation of NaPi-IIa in response to PTH is 
affected by the loss of GABARAP, we injected animals with PTH and quantified 
the amount of NaPi-IIa remaining in renal BBM 45 minutes after injection. 
Based on immunoblot data, administration of PTH led to ~50 % reduction of 
NaPi-IIa in BBM of GABARAP+/+ mice (Fig. 20A). PTH also induced a reduction 
of NaPi-IIa in GABARAP-/- mice. Moreover, despite the higher basal levels in 
GABARAP-/- animals, the amount of NaPi-IIa remaining upon PTH 
administration was similar in both groups of mice (Fig. 20A).  
I then analyzed the Pi transport activity into BBMV isolated from control 
and PTH-injected GABARAP+/+ and GABARAP-/- mice. In agreement with the 
immunoblot data, Na+-dependent uptakes of 32Pi decreased upon PTH 
treatment. Furthermore, similar uptakes were measured in BBMV isolated from 
both groups of animals upon PTH treatment, despite the higher basal uptake 
measured in mutant mice (Fig. 20B).  
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Figure 20: PTH-induced endocytosis of NaPi-IIa in GABARAP+/+ and GABARAP-/- mice.  
 
(A) Representative Immunoblot of NaPi-IIa on BBM isolated from GABARAP+/+ and GABARAP-/- mice 
injected with either saline or PTH. Expression was normalized to β-actin for the quantification. Similar 
results were obtained in six animals per group. (B) Na+-dependent uptake of Pi into BBMV isolated from 
kidneys of GABARAP-/- and GABARAP+/+ mice injected with saline or PTH (n=6). Uptakes were analyzed 
after 1 minute incubation as indicated. Data are means ± SEM. (* p ≤ 0.05, ** p ≤ 0.01, unpaired student t-
test; relative to GABARAP+/+ injected with saline). 
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6.3.2 Adaptation of GABARAP-/- mice to chronic alterations of dietary Pi 
In order to study whether the absence of GABARAP interferes with the 
chronic adaptation to the dietary Pi content, we fed GABARAP+/+ and 
GABARAP-/- mice with either a high (1.2%) or low (0.1%) Pi diet for 5 days. 
Urinary Pi excretion, serum Pi concentration, NaPi-IIa and NaPi-IIc expression 
as well as localization and Pi transport activity were analyzed in these animals. 
 
6.3.2.1 Urinary and serum Pi concentrations 
First, urinary Pi excretion was determined. Both in GABARAP+/+ and 
GABARAP-/- mice the high Pi diet resulted in an increased excretion of Pi in the 
urine as compared with the low Pi chow (Fig. 21A). Under high Pi conditions 
urinary Pi excretion was similar in GABARAP+/+ and GABARAP-/- mice. 
However, urinary Pi excretion was even smaller in GABARAP-/- than in 
GABARAP+/+ mice when animals were fed with a low Pi diet. 
 Serum Pi levels were then compared in these four groups of mice      
(Fig. 20B). In contrast to the urinary Pi excretion, serum Pi levels were similar in 
the groups that received a high and a low Pi diet. Moreover, the levels of Pi in 
serum were also comparable in GABARAP+/+ and GABARAP-/- mice. 
 
 
Figure 21: Chronic adaptation to a high or low dietary Pi content.  
(A) Urinary Pi excretion as a ratio to urinary creatinine in GABARAP+/+ and GABARAP-/- mice fed with 
either a high (↑) or a low (↓) Pi diet for 5 days (n=6). (B) Serum Pi concentration in the same animals. Data 
are means ± SEM. (*** p ≤ 0.001, unpaired student t-test)   
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6.3.2.2 NaPi-IIa and NaPi-IIc expression 
In a next step, I determined the effect of the high /low Pi diets on the 
expression of NaPi-IIa and NaPi-IIc in renal BBM (Fig. 22A). A high dietary Pi 
intake led to a decreased abundance of both transporters as compared to a low 
dietary Pi intake. This reduction was observed in GABARAP+/+ as well as in 
GABARAP-/- mice. NaPi-IIa expression was similar in GABARAP+/+ and in 
GABARAP-/- mice fed with a high Pi diet. However, the expression of NaPi-IIa 
was greater in GABARAP-/- than in GABARAP+/+ mice when the animals 
received a low Pi chow. This is in agreement with the reduced urinary excretion 
of Pi in GABARAP-/- mice under this dietary condition (Fig. 21A). The 
expression and adaptation of NaPi-IIc was similar in GABARAP+/+ and 
GABARAP-/- animals. 
In addition to the protein levels, mRNA abundance of both transporters 
was determined by Real-Time PCR. As shown in Fig. 22B NaPi-IIa mRNA 
expression was similar in all groups suggesting that dietary adaptation of    
NaPi-IIa involves posttranscriptional mechanisms. NaPi-IIc mRNA levels were 
increased in mice fed with a low Pi diet as compared to those that were given a 
high Pi diet. This increase was observed both in GABARAP+/+ and GABARAP-/- 
mice. 
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Figure 22: Expression of NaPi-IIa and NaPi-IIc in mice adapted to chronic high/low dietary Pi. 
(A) Representative Immunoblot of NaPi-IIa and NaPi-IIc on BBM isolated from GABARAP+/+ and 
GABARAP-/- mice fed with either a high (↑) or a low (↓) Pi diet. Expression was normalized to β-actin for 
the quantification. Similar results were obtained in six animals per group. (B) Real-Time PCR to determine 
NaPi-IIa (left) and NaPi-IIc (right) mRNA levels normalized to HPRT (n=6). Data are means ± SEM. (* p ≤ 
0.05; ** p ≤ 0.01, unpaired student t-test)   
 
 
In agreement with the Immunoblot data (Fig. 22) the low Pi diet increased 
the immunofluorescence signal of NaPi-IIa and NaPi-IIc in kidney slices. 
However, GABARAP+/+ and GABARAP-/- mice displayed the same subcellular 
pattern and distribution of NaPi-IIa and NaPi-IIc along the nephron segments 
both under chronic low or high Pi intake (Fig. 23). 
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Figure 23: Localization of NaPi-IIa and NaPi-IIc after chronic adaptation to a high or low Pi diet.  
Immunostaining of (A) NaPi-IIa and (B) NaPi-IIc on kidney cryosections obtained from GABARAP+/+ (left) 
and GABARAP-/- mice (right). Upper panels show cryosections from mice fed with a low Pi diet. Lower 
panels show cryosections from mice fed with a high Pi diet. Renal cortical overviews are displayed as 
grayscale figure.  
 
6.3.2.3 Pi Transport activity  
Based on the immunoblot and immunohistochemistry data the dietary Pi 
content is a prominent regulator of NaPi-IIa and NaPi-IIc expression. In addition, 
the loss of GABARAP causes a more pronounced upregulation of NaPi-IIa 
when mice are fed with a low Pi diet (Fig. 22A). In order to determine whether 
the detected protein levels correlate with Pi transport activity, we analyzed the 
Pi uptake into renal BBMV isolated from the same mice (Fig. 24). Uptake of 32Pi 
into BBMV was significantly smaller in the groups that were fed with a high Pi 
diet than in those mice fed with a low Pi chow. No difference between 
GABARAP+/+ and GABARAP-/- mice was observed under a high Pi diet. When 
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fed with a low Pi diet, uptake into GABARAP-/- BBMV tended to be bigger than 
in GABARAP+/+, but the difference was just below statistical significance 
(p=0.054).   
 
 
 
Figure 24: Na+-dependent 32P uptake into renal BBMV after chronic adaptation to a high or a low Pi 
diet.  
 
Na+-dependent uptake of Pi into BBMV isolated from kidneys of GABARAP+/+ and GABARAP-/- fed with 
either a high (↑) or a low (↓) Pi diet (n=6). Uptakes were analyzed after 30 seconds incubation as indicated. 
Data are means ± SEM. (* p ≤ 0.05, unpaired student t-test) 
 
 
6.3.3 Adaptation of GABARAP-/- mice to acute switches of dietary Pi 
To study if the acute adaptation to the dietary content of Pi is affected by the 
absence of GABARAP the effect of rapid switches of the diet was analyzed. 
 
6.3.3.1 Switch from low to high Pi diet 
Mice were fed with a low Pi diet for 5 days. On day 5, the mice were 
either kept on low Pi diet or were switched to a high Pi diet for four hours. 
Urinary Pi excretion, serum Pi concentration and NaPi-IIa expression were 
analyzed in these animals. 
First, urinary Pi excretion was determined. The switch to a high Pi diet 
resulted in an increased excretion of Pi in the urine as compared with the urine 
of those animals that stayed with the low Pi diet (Fig. 25A). This adaptation was 
observed both in GABARAP+/+ and in GABARAP-/- mice. Although urinary Pi 
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excretion tended to be smaller in GABARAP-/- than in GABARAP+/+ mice the 
difference was not significant.  
 Serum Pi levels were compared in these animals as shown in figure 25B. 
In contrast to chronic adaptation (Fig. 21B), an acute change in dietary Pi intake 
leads to changes in serum Pi concentrations. Mice that were switched from a 
low to a high Pi diet had significantly higher serum Pi levels compared to the 
groups that were kept on low Pi diet. No difference between GABARAP+/+ and 
GABARAP-/- mice was observed with regard to the serum Pi levels. 
 Mice that were switched to a high Pi diet displayed a significantly 
reduced abundance of NaPi-IIa compared to those animals that were kept on 
the low Pi chow (Fig. 25C). This rapid downregulation of NaPi-IIa was not 
affected by the absence of GABARAP since NaPi-IIa expression was 
comparable between GABARAP+/+ and GABARAP-/- mice. Surprisingly, under 
these dietary condition (2 hrs feeding period per day) the levels of NaPi-IIa were 
similar in GABARAP-/- and in GABARAP+/+ mice. 
 
 
Figure 25: Acute switch from a low to a high Pi diet.  
(A) Urinary Pi excretion as a ratio to urinary creatinine in GABARAP+/+ and GABARAP-/- mice fed with a 
low Pi diet (↓↓) for 5 days (n=3) compared to animals that were fed with a low Pi diet for 5 days and then 
swiched to a high Pi diet (↓↑) for four hours (n=5). (B) Serum Pi concentration in the same animals. (C) 
Representative Immunoblot of NaPi-IIa on BBM of the same animals. Expression was normalized to β-
actin for the quantification. Data are means ± SEM. (*p ≤ 0.05,  **p  ≤ 0.01, *** p ≤ 0.001, unpaired student 
t-test)   
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6.3.3.2 Switch from high to low Pi diet 
GABARAP+/+ and GABARAP-/- mice were fed with a high Pi diet for 5 
days. On the last day, some animals were kept on a high Pi chow whereas 
others were switched to low Pi diet for four hours. Urinary Pi excretion, serum Pi 
concentration and NaPi-IIa expression were determined. 
Mice that were switched to a low Pi diet displayed a significantly 
decreased urinary Pi excretion than those that still received the high Pi chow 
(Fig. 26A). However, there was no difference between GABARAP+/+ and 
GABARAP-/- mice in any of the two dietary conditions.   
 As indicated above for the acute high to low Pi diet switch, also the acute 
low to high adaptaion caused alterations of the serum Pi concentrations. The 
mice that were acutely switched to a low Pi diet had significantly lower serum Pi 
levels than mice that were kept on high Pi diet (Fig. 26B). No difference 
between GABARAP+/+ and GABARAP-/- mice was observed with regard to the 
serum Pi levels. 
 Mice switched to a low Pi diet on the last day of the experiment had a 
higher NaPi-IIa abundance than those that still got the high Pi diet (Fig. 26C).  
Upregulation of NaPi-IIa was similar in GABARAP+/+ and GABARAP-/- mice. As 
for the opposite acute switch, the basal expression of NaPi-IIa was similar in 
GABARAP+/+ and GABARAP-/- mice, possibly due to the reduced food intake 
during the 2 hrs feeding period. 
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Figure 26: Acute switch from a high to a low Pi diet. 
(A) Urinary Pi excretion as a ratio to urinary creatinine in GABARAP+/+ and GABARAP-/- mice fed with a 
high Pi diet (↑↑) for 5 days (n=3) compared to animals that were fed with a high Pi diet for 5 days and then 
swiched to a low Pi diet (↑↓) for four hours (n=5). (B) Serum Pi concentration in the same animals. (C) 
Representative Immunoblot of NaPi-IIa on BBM of the same animals. Expression was normalized to β-
actin for the quantification. Data are means ± SEM. ( **p  ≤ 0.01, *** p ≤ 0.001, unpaired student t-test)   
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7. Discussion 
 
Renal Pi reabsorption is mainly determined by the expression of NaPi-IIa 
in the BBM of proximal tubules in mice. Apical positioning and membrane 
abundance of NaPi-IIa depends on a network of interacting proteins. In a 
membrane yeast-two-hybrid screen using the functional cotransporter lacking 
the previously identified C-terminal PDZ-binding motif as bait, GABARAP was 
found as a putative novel interacting partner of NaPi-IIa. Therefore, the first aim 
of this study was to confirm the interaction between NaPi-IIa and GABARAP. In 
a next step the physiological role of the interaction between GABARAP and 
NaPi-IIa was studied in a GABARAP-/- mouse model.   
 
 
7.1 Renal expression of GABARAP 
GABARAP mRNA has been previously shown to be expressed in various 
tissues, including the kidneys (Xin, Yu et al. 2001). However, no detailed 
information regarding the mRNA distribution within the kidney was available. 
Therefore, I performed Real-Time PCR analysis on RNA isolated from 
dissected murine nephrons. GABARAP mRNA was detected in all tested 
segments along the nephron at similar, relatively high expression levels. In 
order to rule out cross-contaminations with mRNA from different nephron 
segments, I additionally analyzed the expression profile of marker genes which 
are known to be differentially expressed along the nephron. NaPi-IIa was 
chosen as a marker for proximal tubules. Its mRNA has been shown to be 
highly abundant in proximal convoluted tubules (S1 and S2) and to be 
expressed to a lesser extend also in S3 segments (Madjdpour, Bacic et al. 
2004). NaPi-IIa mRNA is absent in the more distal tubule (Custer, Meier et al. 
1993). Using β-ENaC as a second marker, I was aiming to demonstrate the 
enrichment of distal nephron segments. β-ENaC mRNA is present in the distal 
concoluted tubule, the cortical collecting duct (CCD) and the outer medullary 
collecting ducts (Vehaskari, Hempe et al. 1998). For both markers, we could 
detect the mRNA only in those nephrons in which their expression has been 
described earlier. Therefore, it is unlikely that the uniform GABARAP mRNA 
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distribution along the nephron is due to segments cross-contamination. 
Importantly for our study, GABARAP mRNA expression was detected in 
proximal convoluted and proximal straight tubules, those segments where  
NaPi-IIa mRNA is also present. 
 Endogenous GABARAP protein expression has been reported in rat 
brain, liver, kidney, spleen, skeletal muscle and heart (Tanida, Ueno et al. 2004) 
as well as in various human cell lines (Green, O'Hare et al. 2002). Immunoblot 
using an antibody raised against human GABARAP (Green, O'Hare et al. 2002) 
confirmed its expression in murine BBM preparations. In addition to the band at 
the expected molecular weight of 17 kDa a second product of faster mobility 
was detected. This second product has been suggested to represent a lipidated 
form of GABARAP (Tanida, Ueno et al. 2004). Both bands were specific to 
GABARAP as indicated by their absence in BBM preparations from GABARAP-/- 
mice.  
 GABARAP immunostainings show a punctate distribution within the 
cytoplasm of breast epithelial cells, HeLa cells and neurons (Wang, Bedford et 
al. 1999; Kneussel, Haverkamp et al. 2000; Green, O'Hare et al. 2002; Klebig, 
Seitz et al. 2005). Interestingly, GABARAP does not co-localize with the         
γ2-subunit of GABAA-receptors or with gephyrin in mouse retina sections 
(Kneussel, Haverkamp et al. 2000). Unfortunately, our attempts to identify the 
localization of GABARAP in the kidney failed, since similar signals were 
detected in cryosections from GABARAP+/+ and GABARAP-/- kidneys (data not 
shown). These signals could represent either non-specific binding of the 
antibody to renal tissue or cross-reaction with the GABARAP-like proteins 
GABARAPL1 and GABARAPL2. Both paralogs are expressed in kidney, albeit 
at very low levels (Sagiv, Legesse-Miller et al. 2000; Wang, Dun et al. 2006). 
Despite this technical caveat, the presence of GABARAP in BBM preparations 
points to a subcellular proximity of GABARAP and NaPi-IIa, making the 
interaction between both proteins plausible. 
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7.2 Interaction between GABARAP and NaPi-IIa 
The interaction of GABARAP and NaPi-IIa was verified by GST-pull 
downs and by co-immunoprecipitation from transfected HEK293 cells. Taken 
together, these data suggest that NaPi-IIa and GABARAP associate in vitro and 
may also interact with each other in vivo. Furthermore, the sites involved in the 
protein-protein interation were partially characterized. It has been reported that 
the association of GABARAP with the γ-subunit of GABAA-receptors depends 
on a region between the amino acids 36-68 of GABARAP (Wang, Bedford et al. 
1999). In order to find the molecular determinant of GABARAP that mediates 
the interaction with NaPi-IIa, we expressed two overlapping halves of 
GABARAP (aa 1-68 and aa 37-117, respectively) fused to GST as described 
(Wang, Bedford et al. 1999). Both fusion proteins were capable of pulling down 
NaPi-IIa from BBM, suggesting that similar to the GABAA-receptor γ-subunit the 
interaction of GABARAP with NaPi-IIa involves the region between the amino 
acids 36-68 of GABARAP. GABARAP 36-117 has been shown to interact also 
with the transferrin receptor (Green, O'Hare et al. 2002). Therefore, these 
internal residues might represent a common motif for protein-protein 
interactions.  
Recently, a consensus sequence for GABARAP-binding was proposed 
based on the binding sites of calreticulin, clathrin heavy chain as well as the   
γ2-subunit of the GABAA receptor. This consensus sequence contains few 
amino acids that surround a highly conserved tryptophan residue. These 
residues interact with a hydrophobic patch on the surface of GABARAP 
(Thielmann, Mohrluder et al. 2008). We identified a sequence that would fit to 
this motif in the C-terminus of NaPi-IIa. Therefore, pull downs were performed 
with lysates from HEK293 cells transfected either with the full length or a 
truncated cotransporter (Δ571) which lacks the tryptophan-containing peptide. 
Both the full length and the truncated NaPi-IIa were pulled down by GST-
GABARAP. Although these data does not rule out its potential implication in 
vivo, it suggests that the mentioned C-terminal peptide of NaPi-IIa is not 
required for the in vitro interaction with GABARAP. Since pull-down experiments 
using discrete intracellular domains of NaPi-IIa failed and I was unable to 
identify conditions which allow the expression of membrane domains of NaPi-IIa 
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in E.coli or cultured cells, the domain of NaPi-IIa that mediates the interaction 
with GABARAP remains elusive. 
 
 
7.3 Metabolic characterization of GABARAP-/- mice 
The generation of GABARAP-/- mice by gene trap methodology has been 
described (O'Sullivan, Kneussel et al. 2005). It was reported that these animals 
show a normal phenotype with regard to the expression of GABAA receptor γ2-
subunit in synapses. The lack of a phenotype for the GABAA receptor 
expression in inhibitory synapses in the brain is in conflict with results obtained 
in in vitro studies in which overexpression of GABARAP increased the 
membrane abundance of GABAA receptors (Chen, Wang et al. 2000; Leil, Chen 
et al. 2004; Chen, Chang et al. 2007). This discrepancy has been attributed to a 
compensatory effect of GABARAPL1 and/or GABARAPL2 in mice. In particular 
GABARAPL2 has also been shown to interact with the GABAA receptor and 
tubulin (Mansuy, Boireau et al. 2004). These studies were performed only with 
regard to the GABAA receptor expression in the brain. The GABARAP-/- mice 
were not further characterized justifying a detailed study of their metabolic 
status. 
GABARAP-/- mice had a higher body weight as compared to 
GABARAP+/+ mice of a the same age. This increased body weight of is not due 
to a higher dietary intake, since GABARAP-/- and GABARAP+/+ animals 
consumed similar amounts of food. I observed a higher fat content in the 
abdomen of GABARAP-/- mice compared to GABARAP+/+ mice while harvesting 
the kidneys, but I did not perform further studies with regard to the differences in 
body weight. 
 GABARAP-/- mice drank less water as compared to GABARAP+/+ mice. 
In a recent report the interaction between GABARAP and the angiotensin II type 
I receptor has been described. Similar to the findings concerning the GABAA 
receptor, overexpression of GABARAP increased the surface expression of the 
angiotensin II type I receptor in cells (Cook, Re et al. 2008). As angiotensin II 
acts on the hypothalamus to increase the sensation of thirst (Boron and 
Boulpaep 2005), the lack of GABARAP might influence the drinking behavior of 
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GABARAP-/- mice. The reduced intake of water in the mutant mice translated in 
a reduced urinary output. The excreted urine of GABARAP-/- mice displayed an 
increased osmolarity and also a higher creatinine concentration. Urine 
concentration and dilution is mainly mediated by regulation of Aquaporin 2 
water channels in the apical membrane of principal cells of the collecting 
tubules and ducts (Boron and Boulpaep 2005). Regulation of Aquaporin 2 
occurs at the transcriptional and posttranscriptional level (Deen, Verdijk et al. 
1994). In an attempt to investigate the reduced urinary output of GABARAP-/- 
mice in further detail, I determined AQP2 mRNA levels in kidneys isolated from 
GABARAP-/- and GABARAP+/+ mice by Real-Time PCR. When normalized to 
HPRT mRNA expression, AQP2 mRNA levels were similar in GABARAP+/+ and 
GABARAP-/- mice (data not shown). This suggests that the absence of 
GABARAP does not induce changes of AQP2 mRNA. 
The rationale of our study was to investigate, whether the interaction with 
GABARAP influences the membrane expression of NaPi-IIa and thus renal 
handling of Pi. Therefore, I compared the urinary Pi excretion of GABARAP-/- 
and GABARAP+/+ mice. In these experiments, the urinary creatinine 
concentration was used to normalize for the different urinary volume excreted 
by both groups. We found that urinary Pi excretion was significantly reduced in 
GABARAP-/- as compared to GABARAP+/+ mice. This reduced excretion was 
specifically found for Pi, since the excretion of all other tested ions was 
comparable in both groups after normalization to urinary creatinine.  
Interestingly, the serum concentration of Pi was similar in GABARAP+/+ 
and GABARAP-/- mice. Whether this is related to a higher metabolic 
consumption of Pi in GABARAP-/- mice, due for instance to their higher body 
weight, or to some compensatory mechanism(s) such as reduced intestinal 
absorption or enhanced bone deposition will be discussed later (section 7.5). 
Interestingly, the Ca2+ concentration in blood was also similar in both groups of 
animals. This is important, since plasma Ca2+ regulates PTH secretion by the 
parathyroid gland in a negative feedback loop (Boron and Boulpaep 2005). 
Since serum Ca2+ and Pi concentrations were both unchanged, serum PTH 
levels might be similar in GABARAP+/+ and GABARAP-/- animals. Unfortunately, 
this remains speculative, since our attempts to measure serum PTH levels 
failed due to a lack of sensitivity of the assay. The PTH receptor belongs to the 
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family of G-protein coupled receptors and it signals via Gs and Gq/i,o as indicated 
before. Therefore binding of PTH leads to intracellular accumulation of cAMP 
and Ca2+. We measured the concentration of cAMP in the urine and found no 
difference between GABARAP+/+ and GABARAP-/- mice suggesting that the 
basal cAMP status is similar in both groups of animals.  
In summary, the changes in urinary Pi excretion validated a study of a 
potential role of GABARAP in NaPi-IIa expression and regulation 
 
 
7.4 NaPi-IIa abundance and activity in GABARAP-/- mice under 
normal conditions 
Urinary excretion of Pi is mostly controlled by the rate of reabsorption in 
the proximal tubule (Forster, Hernando et al. 2006). NaPi-IIa is believed to be 
the main Na-dependent Pi cotransporter in mice based on the severe renal 
wasting phenotype of NaPi-IIa-/- mice (Beck, Karaplis et al. 1998) as well as on 
RNA hybrid depletion experiments (Segawa, Kaneko et al. 2002). NaPi-IIc was 
considered to play only a minor role. However, mutations of NaPi-IIc were 
recently identified in families with several hypophosphatemic syndromes 
(Bergwitz, Roslin et al. 2006; Ichikawa, Sorenson et al. 2006; Lorenz-
Depiereux, Benet-Pages et al. 2006). Thus, either renal Pi reabsorption differs 
greatly between human and mice or the renal Pi handling is still not understood 
completely. 
 Therefore, I next analyzed whether the reduced urinary excretion of Pi 
detected in GABARAP-/- mice was due to changes on the expression of      
NaPi-IIa. In addition, I also analyzed the expression of NaPi-IIc. I found that 
NaPi-IIa (but not NaPi-IIc) abundance was significantly increased in renal BBM 
of GABARAP-/- as compared to GABARAP+/+ mice. Furthermore, the increased 
NaPi-IIa membrane abundance was reflected by a higher Na-dependent Pi 
transport activity across the BBM as demonstrated by uptake experiments. 
These results are in line with the reduced urinary Pi excretion of GABARAP-/- 
mice. Thus, the absence of GABARAP leads to upregulation of surface-
expressed NaPi-IIa. In contrast to this effect on NaPi-IIa, overexpression of 
GABARAP in different cell lines was previously shown to increase the 
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membrane abundance of the GABAA receptor as well as the angiotensin II type 
I receptor (Leil, Chen et al. 2004; Cook, Re et al. 2008). It was concluded from 
these data that GABARAP acts as a general trafficking protein along the 
biosynthetic pathway which increases the membrane abundance of its 
interacting membrane partners. However, as mentioned before, no phenotype 
with regard to the GABAA receptors has been observed in GABARAP-/- mice 
(O'Sullivan, Kneussel et al. 2005). This disagreement between in vivo and in 
vitro studies could be due to a compensatory mechanism in the in vivo studies 
or to inadecuate cellular models in the in vitro studies. Alternatively, despite its 
ability to interact with various membrane proteins through a common motif, 
GABARAP might exert different effects on the respective interacting partner. 
This could depend on the tissue-specific expression of a certain set of 
interacting proteins that form the network in which the membrane protein is 
embedded.  
Interestingly, the crystal-structure of GABARAP revealed the presence of 
a motif which resembles an ubiquitin-like fold (Bavro, Sola et al. 2002). 
Furthermore, it has been shown that GABARAP can be processed by a set of 
E1- and E2-like enzymes in a similar way than ubiquitin (Tanida, Ueno et al. 
2004). At the end of this ubiquitin-like processing, GABARAP is conjugated to 
phospholipids rather than to proteins (Sou, Tanida et al. 2006). This mechanism 
has only been studied in vitro. The impact of membrane conjugation of 
GABARAP on the expression/stability of membrane proteins such as NaPi-IIa 
remains to be established.  
Another mechanism to explain the increased NaPi-IIa abundance in BBM 
is the upregulation of its important scaffolding protein NHERF1. Studies in OK 
cells have shown that the apical expression of NaPi-IIa decreases when its 
association with NHERF1 is prevented (Hernando, Deliot et al. 2002). 
Furthermore, NHERF1-/- mice show a reduced expression of NaPi-IIa in the 
proximal BBM associated with higher intracellular levels (Shenolikar, Voltz et al. 
2002). Thus, we can speculate that increased amounts of NHERF1 might result 
in a higher surface expression of NaPi-IIa. Indeed higher levels of NHERF1 
were detected in kidneys of GABARAP-/- mice. However, the mechanism 
underlying the upregulation of NHERF1 in the absence of GABARAP remains to 
be addressed in further studies. 
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Changes on NaPi-IIa abundance in response to acute stimuli are due to 
regulated insertion/retrieval from the BBM rather than to changes on mRNA 
levels (Levi, Lotscher et al. 1994; Forster, Hernando et al. 2006) whereas 
chronic adaptation to dietary Pi may (Levi, Lotscher et al. 1994) or may not 
involve transcriptional regulation (Madjdpour, Bacic et al. 2004). Therefore, we 
quantified the amount of NaPi-IIa mRNA in kidneys from GABARAP+/+ and 
GABARAP-/- mice by Real-Time PCR. NaPi-IIa mRNA expression levels were 
comparable in both groups of animals. Therefore, upregulation of the 
cotransporter in GABARAP-/- mice is most likely due to posttranscriptional 
mechanisms. As reported previously (Madjdpour, Bacic et al. 2004), the 
expression of NaPi-IIc mRNA was very low as compared to NaPi-IIa and its 
levels were similar in GABARAP+/+ and GABARAP-/- kidneys.  
In summary, these data suggest that under normal conditions GABARAP 
plays a suppressive role in the expression/stabilization of NaPi-IIa in renal 
proximal tubules and its absence cannot be compensated by GABARAP-like 
paralogs as it has been proposed for the expression of GABAA receptors 
(O'Sullivan, Kneussel et al. 2005).  
 
 
7.5 Pi homeostasis in GABARAP-/- mice under normal conditions 
Despite the reduced urinary excretion of Pi (associated with higher   
NaPi-IIa levels), GABARAP-/- mice have normal circulating levels of this 
element, suggesting the presence of a compensatory mechanism that prevents 
the animals from becoming hyperphosphatemic. Pi homeostasis is achieved by 
a coordinated absorption of Pi from the diet and renal Pi excretion. In addition, 
bone formation and resorption can help to maintain serum Pi levels in a 
constant millimolar range.  
 Pi absorption from the diet occurs in the small intestine in a Na-
dependent as well as in a Na-independent manner. In contrast to the             
Na-dependent transport of Pi across the membrane, Na-independent Pi 
transport is not regulated (Lee, Walling et al. 1986). In mice, NaPi-IIb is 
expressed in the luminal membrane of enterocytes and is considered to be the 
main NaPi cotransporter in the small intestine (Hilfiker, Hattenhauer et al. 1998). 
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In mice, NaPi-IIb expression is highest in the ileum and only little amounts are 
found in other segments such as duodenum and jejunum (Marks, Srai et al. 
2006). Although intestinal Pi absorption is not regulated in response to acute 
stimulus, chronic situations such as a prolonged intake of a low Pi diet lead to 
adaptive changes of NaPi-IIb (Hattenhauer, Traebert et al. 1999; Radanovic, 
Wagner et al. 2005). Experiments in Xenopus laevis oocytes suggest that in 
contrast to NaPi-IIa, regulation of NaPi-IIb involves ubiquitination by the 
ubiquitin-ligase Nedd4-2 which is in turn regulated through its phosphorylation 
by the Serum and Glucocorticoid-Inducible kinase 1 (SGK1) (Palmada, Dieter et 
al. 2004). NaPi-IIb abundance was significantly decreased in the BBM of the 
ileum of GABARAP-/- compared to GABARAP+/+ mice. A decreased intestinal Pi 
absorption could act as compensatory mechanism in order to balance the 
hypophosphaturia observed in GABARAP-/- mice. However, it remains to be 
established whether this decreased abundance of the cotransporter correlates 
with a lower intestinal Pi absorption in GABARAP-/- mice and what is the 
mechanism underlying this finding. In preliminary experiments using GST-
GABARAP in order to pull down NaPi-IIb from intestinal BBM, no evidence for a 
direct interaction between GABARAP and NaPi-IIb could be obtained (data not 
shown). Pi absorption in the small intestine is influenced by the active vitamin D 
metabolite 1,25-dihydroxyvitamin D3. Higher 1,25-dihydroxyvitamin D3 levels 
increase the abundance of NaPi-IIb protein in the BBM (Hattenhauer, Traebert 
et al. 1999; Xu, Bai et al. 2002). Increase of active 1,25-dihydroxyvitamin D3 
occurs via stimulation of the renal 25-hydroxyvitamin-D3-1α-hydroxylase. 
Control of the 25-hydroxyvitamin-D3-1α-hydroxylase takes place at the level of 
its mRNA (Wu, Finch et al. 1996; Brown, Dusso et al. 1999). Interestingly, renal 
25-hydroxyvitamin-D3-1α-hydroxylase mRNA levels were reduced in 
GABARAP-/- mice (data not shown). Taken together, these findings suggest that 
the lower NaPi-IIb abundance in the absence of GABARAP is a compensatory 
mechanism that is independent on a physical interaction between NaPi-IIb and 
GABARAP. Instead it might be achieved by reduced levels of                       
1,25-dihydroxyvitamin D3, although this remains to be proved. 
 
 As mentioned before, Pi (as hydroxyapatite) is an essential component of 
the mineralized bone matrix. The bone is a dynamic tissue which is constantly 
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built by osteoblasts and resorbed by osteoclasts. Several NaPi-cotransporters 
including   PiT-1, PiT-2 (Nielsen, Pedersen et al. 2001) as well as NaPi-IIa and 
NaPi-IIb (Lundquist, Murer et al. 2007) have been shown to be expressed in 
cultured osteoblast-like cells. Na-dependent Pi transport into osteoblast-like 
cells has been reported to be modulated by PTH (Selz, Caverzasio et al. 1989) 
as well as by the presence of extracellular Pi (Lundquist, Murer et al. 2007). 
NaPi-IIa and PiT-1 expression have been also reported in cultured osteoclast 
cells (Gupta, Guo et al. 1997; Gupta, Tenenhouse et al. 2001). Furthermore, the 
number of osteoclasts is decreased in young NaPi-IIa-/- mice (Gupta, 
Tenenhouse et al. 2001), but the bone content of Pi was not determined. In 
order to test whether the loss of GABARAP affects the Pi and Ca2+ content in 
bone, we analyzed bone ashes from GABARAP+/+ and GABARAP-/- mice. The 
content of both major bone components was similar in both groups.  
Taken together, our data indicate that the reduced intestinal absorption 
may compensate for the increased renal Pi reabsorption in GABARAP-/- mice 
without an apparent involvement of the skeleton. 
 
 
7.6 Regulation of NaPi-IIa by PTH in GABARAP-/- mice 
As discussed above, GABARAP-/- mice show higher levels of NaPi-IIa in 
renal BBM together with a higher expression of NHERF1. In principle, 
upregulation of NaPi-IIa on steady-state conditions could be due to an 
increased rate of membrane insertion, reduced membrane removal or changes 
on membrane stability. Therefore I analyzed the behavior of NaPi-IIa in 
response to maneuvers that control (acutely/chronically) the removal and 
membrane insertion of the cotransporter. 
PTH is a potent phosphaturic hormone which causes the internalization 
of NaPi-IIa. As described before, rapid internalization of NaPi-IIa in response to 
PTH occurs most likely via the pathway of receptor-mediated endocytosis 
(Kempson, Helmle et al. 1990; Bacic, Lehir et al. 2006). This pathway involves 
clathrin-coated vesicles which fuse with the early endosomes. An interaction 
between the clathrin heavy chain and GABARAP has been reported (Mohrluder, 
Hoffmann et al. 2007), but the physiological relevance of this interaction has not 
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been addressed. I analyzed whether PTH-induced downregulation of NaPi-IIa is 
affected by the lack of GABARAP. NaPi-IIa downregulation in response to PTH 
was not impaired in GABARAP-/- mice and, despite a higher basal abundance of 
NaPi-IIa, expression levels after PTH-injections were reduced to similar levels in 
GABARAP+/+ and GABARAP-/- mice. These data indicate that the higher basal 
NaPi-IIa levels can not be explained by a decreased responsiveness for PTH in 
GABARAP-/- mice. 
 
 
7.7 Dietary regulation of NaPi-IIa in GABARAP-/- mice 
Changes in the dietary intake of Pi affect the renal Pi excretion by adjusting the 
amount of NaPi-IIa in the apical microvilli. The expression of NaPi-IIa in the 
BBM increases in response to a low dietary intake of Pi, whereas in conditions 
of high dietary Pi the level of NaPi-IIa decreases (Biber, Hernando et al. 2008). 
Both responses are fast and can be detected few hours (acute adaptation) after 
Pi ingestion (Levine, Ho et al. 1986). Acute downregulation of NaPi-IIa relays on 
its endocytic retrieval and lysosomal degradation, similar to the PTH effect 
(Keusch, Traebert et al. 1998). Acute upregulation does not require de novo 
synthesis; instead it depends on an intact microtubular cytoskeleton, suggesting 
the sorting of intracellularly stored NaPi-IIa to the BBM. Neither acute 
upregulation nor acute downregulation of NaPi-IIa was impaired in GABARAP-/- 
mice. These data suggest that the acute dietary regulation of NaPi-IIa does not 
require the presence of GABARAP. Furthermore, together with the PTH data, it 
suggests that at least the regulated membrane retrieval/insertion of NaPi-IIa is 
not impaired in the absence of GABARAP. 
The capacity of renal Pi reabsorption remains adjusted even during prolonged 
intake of dietary Pi (Levi, Kempson et al. 1996). This regulation involves post-
transcriptional mechanisms for NaPi-IIa whereas NaPi-IIc mRNA levels are 
elevated under a prolonged low Pi diet.  As for PTH, NaPi-IIa is downregulated 
to similar levels in GABARAP-/- and GABARAP+/+ mice chronically fed with a 
high Pi diet. In contrast, NaPi-IIa (but not NaPi-IIc) abundance is higher in 
GABARAP-/- than in GABARAP+/+ mice chronically fed with a low Pi diet, similar 
to the findings reported for a normal dietary Pi intake. Changes of GABARAP 
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abundance (or differentially lipidation) were not observed in the BBM under all 
dietary feeding conditions (data not shown).    
 
In summary, NaPi-IIa expression is reduced to similar levels in GABARAP+/+ 
and GABARAP-/- mice by phosphaturic factors (PTH and high Pi diet). In 
contrast, NaPi-IIa is greater in GABARAP-/- than in GABRAP+/+ both in the 
absence of phosphaturic stimulus (normal diet) and under Pi conserving 
settings (low Pi diet). The greater than normal upregulation of NaPi-IIa in 
response to a low Pi diet is observed after a chronic but not with an acute 
feeding. Taken together these data suggest that GABARAP exerts its effect on 
NaPi-IIa neither in the biosynthetic nor in the degradative pathway, but instead 
negatively influences NaPi-IIa basal turnover/half-life in vivo.  
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8. Future perspectives 
 
In this study, a novel interacting partner of NaPi-IIa, GABARAP, was 
identified and GABARAP-/- mice were initially characterized with regard to Pi 
homeostasis. In these studies a number of interesting aspects were discovered 
which should be addressed in further studies: 
 
a. To fully understand the function of GABARAP in the kidney, it would be 
important to determine its (subcellular) localization. For this purpose, a 
new antibody of sufficient quality would have to be raised and tested.  
 
b. The establishment of a cell culture model with a stable knock-down of 
GABARAP would help to analyze the effect on NaPi-IIa. This cell culture 
model would allow the clarification of the molecular mechanism that 
underlies the increased NaPi-IIa abundance in GABARAP-/- mice. In 
particular, we could test in this model whether GABARAP indeed 
interferes with the basal turnover/half life of NaPi-IIa. 
 
c. GST-pull down did not provide evidence for a direct interaction between 
GABARAP and NHERF1. Therefore, it remains to be clarified how the 
lack of GABARAP increases NHERF1 expression in mice. Furthermore, 
it would be of interest to investigate whether the elevated NHERF1 
abundance itself causes the increased NaPi-IIa BBM expression in 
GABARAP-/- mice (e.g. GABARAP-/-/NHERF1-/- mice) 
 
d. We show that the intestinal NaPi-IIb cotransporter is downregulated in 
GABARAP-/- mice. Further studies should address whether the 
decreased NaPi-IIb abundance in the intestinal BBM correlates with a 
reduced Pi absorption from the diet. As for NHERF1, no interaction 
between GABARAP and NaPi-IIb could be identified so far. Therefore, it 
would be important to understand whether this is indeed only a 
compensatory effect and how it is achieved. 
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e. Various factors influence Pi homeostasis among them PTH, vitamin D, 
insulin, growth hormones, steroid hormones and FGF23. The knowledge 
of the abundance of these factors in GABARAP-/- mice would allow not 
only further clarification of the phenotype of these mice but could also 
allow the identification of patients with a similar phenotype. Eventually, it 
could be tested whether there are patients with mutations in the 
GABARAP gene.   
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